<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Kapitel 24 Referenser | Psykiatriboken</title>
  <meta name="description" content="Kapitel 24 Referenser | Psykiatriboken" />
  <meta name="generator" content="bookdown 0.39 and GitBook 2.6.7" />

  <meta property="og:title" content="Kapitel 24 Referenser | Psykiatriboken" />
  <meta property="og:type" content="book" />
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Kapitel 24 Referenser | Psykiatriboken" />
  
  
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="ordlista.html"/>

<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.1.0/anchor-sections.css" rel="stylesheet" />
<link href="libs/anchor-sections-1.1.0/anchor-sections-hash.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.1.0/anchor-sections.js"></script>
<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/lightable-0.0.1/lightable.css" rel="stylesheet" />



<style type="text/css">
  
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
</style>
<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="1" data-path="prolog.html"><a href="prolog.html"><i class="fa fa-check"></i><b>1</b> Prolog</a></li>
<li class="chapter" data-level="2" data-path="aggression.html"><a href="aggression.html"><i class="fa fa-check"></i><b>2</b> Agressivitet och agitation</a>
<ul>
<li class="chapter" data-level="2.1" data-path="aggression.html"><a href="aggression.html#agiterad-eller-agressiv-patient"><i class="fa fa-check"></i><b>2.1</b> Agiterad eller agressiv patient</a>
<ul>
<li class="chapter" data-level="2.1.1" data-path="aggression.html"><a href="aggression.html#bedömning"><i class="fa fa-check"></i><b>2.1.1</b> Bedömning</a></li>
<li class="chapter" data-level="2.1.2" data-path="aggression.html"><a href="aggression.html#behandlingsprinciper"><i class="fa fa-check"></i><b>2.1.2</b> Behandlingsprinciper</a></li>
<li class="chapter" data-level="2.1.3" data-path="aggression.html"><a href="aggression.html#peroral-behandling"><i class="fa fa-check"></i><b>2.1.3</b> Peroral behandling</a></li>
<li class="chapter" data-level="2.1.4" data-path="aggression.html"><a href="aggression.html#intramuskulär-injektion"><i class="fa fa-check"></i><b>2.1.4</b> Intramuskulär injektion</a></li>
<li class="chapter" data-level="2.1.5" data-path="aggression.html"><a href="aggression.html#ref"><i class="fa fa-check"></i><b>2.1.5</b> Ref</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="3" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html"><i class="fa fa-check"></i><b>3</b> Beroende och missbruk av alkohol och droger</a>
<ul>
<li class="chapter" data-level="3.1" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#inledning"><i class="fa fa-check"></i><b>3.1</b> Inledning</a></li>
<li class="chapter" data-level="3.2" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#epidemiologi"><i class="fa fa-check"></i><b>3.2</b> Epidemiologi</a></li>
<li class="chapter" data-level="3.3" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#konceptualisering"><i class="fa fa-check"></i><b>3.3</b> Konceptualisering</a></li>
<li class="chapter" data-level="3.4" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#abuse-brain"><i class="fa fa-check"></i><b>3.4</b> Beroendets anatomi</a>
<ul>
<li class="chapter" data-level="3.4.1" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#referenser"><i class="fa fa-check"></i><b>3.4.1</b> Referenser</a></li>
</ul></li>
<li class="chapter" data-level="3.5" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#beroendets-fysiologi"><i class="fa fa-check"></i><b>3.5</b> Beroendets fysiologi</a>
<ul>
<li class="chapter" data-level="3.5.1" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#alkohol"><i class="fa fa-check"></i><b>3.5.1</b> Alkohol</a></li>
</ul></li>
<li class="chapter" data-level="3.6" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#kroppen-och-missbruk"><i class="fa fa-check"></i><b>3.6</b> Kroppen och missbruk</a></li>
<li class="chapter" data-level="3.7" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#samband-med-andra-psykiska-sjukdomar"><i class="fa fa-check"></i><b>3.7</b> Samband med andra psykiska sjukdomar</a></li>
<li class="chapter" data-level="3.8" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#att-diagnosticera-beroendesjukdomar"><i class="fa fa-check"></i><b>3.8</b> Att diagnosticera beroendesjukdomar</a>
<ul>
<li class="chapter" data-level="3.8.1" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#klinisk-bild"><i class="fa fa-check"></i><b>3.8.1</b> Klinisk bild</a></li>
</ul></li>
<li class="chapter" data-level="3.9" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#skattningsformulär"><i class="fa fa-check"></i><b>3.9</b> Skattningsformulär</a>
<ul>
<li class="chapter" data-level="3.9.1" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#audit"><i class="fa fa-check"></i><b>3.9.1</b> AUDIT</a></li>
<li class="chapter" data-level="3.9.2" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#dudit"><i class="fa fa-check"></i><b>3.9.2</b> DUDIT</a></li>
<li class="chapter" data-level="3.9.3" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#biologiska-markörer"><i class="fa fa-check"></i><b>3.9.3</b> Biologiska markörer</a></li>
</ul></li>
<li class="chapter" data-level="3.10" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#akut-behandling-av-överdos-och-abstinens"><i class="fa fa-check"></i><b>3.10</b> Akut behandling av överdos och abstinens</a>
<ul>
<li class="chapter" data-level="3.10.1" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#wernicke-encephalopati-och-korsakoff-demens"><i class="fa fa-check"></i><b>3.10.1</b> Wernicke encephalopati och Korsakoff demens</a></li>
</ul></li>
<li class="chapter" data-level="3.11" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#läkemedelsbehandling"><i class="fa fa-check"></i><b>3.11</b> Läkemedelsbehandling</a></li>
<li class="chapter" data-level="3.12" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#psykologisk-och-annan-behandling"><i class="fa fa-check"></i><b>3.12</b> Psykologisk och annan behandling</a></li>
<li class="chapter" data-level="3.13" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#beroendet-i-historien-och-kulturen"><i class="fa fa-check"></i><b>3.13</b> Beroendet i historien och kulturen</a></li>
<li class="chapter" data-level="3.14" data-path="beroende-och-missbruk-av-alkohol-och-droger.html"><a href="beroende-och-missbruk-av-alkohol-och-droger.html#sammanfattning"><i class="fa fa-check"></i><b>3.14</b> Sammanfattning</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="behandling-av-beroendesyndrom.html"><a href="behandling-av-beroendesyndrom.html"><i class="fa fa-check"></i><b>4</b> Behandling av beroendesyndrom</a>
<ul>
<li class="chapter" data-level="4.1" data-path="behandling-av-beroendesyndrom.html"><a href="behandling-av-beroendesyndrom.html#läkemedelsassisterad-rehabilitering-vid-opioidberoende-laro"><i class="fa fa-check"></i><b>4.1</b> Läkemedelsassisterad rehabilitering vid opioidberoende (LARO)</a>
<ul>
<li class="chapter" data-level="4.1.1" data-path="behandling-av-beroendesyndrom.html"><a href="behandling-av-beroendesyndrom.html#buprenorfin-med-naloxon"><i class="fa fa-check"></i><b>4.1.1</b> Buprenorfin (med naloxon)</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="5" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html"><i class="fa fa-check"></i><b>5</b> Rättspsykiatri</a>
<ul>
<li class="chapter" data-level="5.1" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#inledning-1"><i class="fa fa-check"></i><b>5.1</b> Inledning</a></li>
<li class="chapter" data-level="5.2" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#förkortningar"><i class="fa fa-check"></i><b>5.2</b> Förkortningar</a></li>
<li class="chapter" data-level="5.3" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#grundläggande-principer"><i class="fa fa-check"></i><b>5.3</b> Grundläggande principer</a></li>
<li class="chapter" data-level="5.4" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#akut-rättspsykiatrisk-vård"><i class="fa fa-check"></i><b>5.4</b> Akut rättspsykiatrisk vård</a></li>
<li class="chapter" data-level="5.5" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#paragraf-sju"><i class="fa fa-check"></i><b>5.5</b> Paragraf 7-undersökning</a></li>
<li class="chapter" data-level="5.6" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#rättspsykiatrisk-undersökning-rpu"><i class="fa fa-check"></i><b>5.6</b> Rättspsykiatrisk undersökning (RPU)</a></li>
<li class="chapter" data-level="5.7" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#rättspsykiatrisk-vård-efter-dom"><i class="fa fa-check"></i><b>5.7</b> Rättspsykiatrisk vård efter dom</a>
<ul>
<li class="chapter" data-level="5.7.1" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#vårdens-innehåll"><i class="fa fa-check"></i><b>5.7.1</b> Vårdens innehåll</a></li>
<li class="chapter" data-level="5.7.2" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#friförmåner"><i class="fa fa-check"></i><b>5.7.2</b> Friförmåner</a></li>
</ul></li>
<li class="chapter" data-level="5.8" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#annan-rättpsykiatrisk-öppenvård"><i class="fa fa-check"></i><b>5.8</b> Annan rättpsykiatrisk öppenvård</a></li>
<li class="chapter" data-level="5.9" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#allvarlig-psykisk-störning"><i class="fa fa-check"></i><b>5.9</b> Allvarlig psykisk störning</a></li>
<li class="chapter" data-level="5.10" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#riskbedömning"><i class="fa fa-check"></i><b>5.10</b> Riskbedömning</a></li>
<li class="chapter" data-level="5.11" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#juridisk-terminologi"><i class="fa fa-check"></i><b>5.11</b> Juridisk terminologi</a></li>
<li class="chapter" data-level="5.12" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#resurser"><i class="fa fa-check"></i><b>5.12</b> Resurser</a>
<ul>
<li class="chapter" data-level="5.12.1" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#artiklar"><i class="fa fa-check"></i><b>5.12.1</b> Artiklar</a></li>
<li class="chapter" data-level="5.12.2" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#böcker"><i class="fa fa-check"></i><b>5.12.2</b> Böcker</a></li>
<li class="chapter" data-level="5.12.3" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#webbsidor"><i class="fa fa-check"></i><b>5.12.3</b> Webbsidor</a></li>
<li class="chapter" data-level="5.12.4" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#rapporter"><i class="fa fa-check"></i><b>5.12.4</b> Rapporter</a></li>
<li class="chapter" data-level="5.12.5" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#lagtexter"><i class="fa fa-check"></i><b>5.12.5</b> Lagtexter</a></li>
<li class="chapter" data-level="5.12.6" data-path="rattspsykiatri.html"><a href="rattspsykiatri.html#se-även"><i class="fa fa-check"></i><b>5.12.6</b> Se även</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="6" data-path="depression.html"><a href="depression.html"><i class="fa fa-check"></i><b>6</b> Depression</a>
<ul>
<li class="chapter" data-level="6.1" data-path="depression.html"><a href="depression.html#diagnoskriterier-enligt-icd-10"><i class="fa fa-check"></i><b>6.1</b> Diagnoskriterier enligt ICD-10</a></li>
<li class="chapter" data-level="6.2" data-path="depression.html"><a href="depression.html#medicinska-differentialdiagnoser-och-basal-utredning"><i class="fa fa-check"></i><b>6.2</b> Medicinska differentialdiagnoser och basal utredning</a></li>
<li class="chapter" data-level="6.3" data-path="depression.html"><a href="depression.html#behandling"><i class="fa fa-check"></i><b>6.3</b> Behandling</a></li>
<li class="chapter" data-level="6.4" data-path="depression.html"><a href="depression.html#läkemedelsbehandling-1"><i class="fa fa-check"></i><b>6.4</b> Läkemedelsbehandling</a>
<ul>
<li class="chapter" data-level="6.4.1" data-path="depression.html"><a href="depression.html#val-av-första-behandling"><i class="fa fa-check"></i><b>6.4.1</b> Val av första behandling</a></li>
<li class="chapter" data-level="6.4.2" data-path="depression.html"><a href="depression.html#uppföljning-av-behandlingseffekt"><i class="fa fa-check"></i><b>6.4.2</b> Uppföljning av behandlingseffekt</a></li>
<li class="chapter" data-level="6.4.3" data-path="depression.html"><a href="depression.html#monitorering"><i class="fa fa-check"></i><b>6.4.3</b> Monitorering</a></li>
<li class="chapter" data-level="6.4.4" data-path="depression.html"><a href="depression.html#byte-av-antidepressiva"><i class="fa fa-check"></i><b>6.4.4</b> Byte av antidepressiva</a></li>
<li class="chapter" data-level="6.4.5" data-path="depression.html"><a href="depression.html#svårbehandlad-depression"><i class="fa fa-check"></i><b>6.4.5</b> Svårbehandlad depression</a></li>
<li class="chapter" data-level="6.4.6" data-path="depression.html"><a href="depression.html#augmentationsbehandling"><i class="fa fa-check"></i><b>6.4.6</b> Augmentationsbehandling</a></li>
<li class="chapter" data-level="6.4.7" data-path="depression.html"><a href="depression.html#kombinationsbehandling"><i class="fa fa-check"></i><b>6.4.7</b> Kombinationsbehandling</a></li>
<li class="chapter" data-level="6.4.8" data-path="depression.html"><a href="depression.html#dosering-av-antidepressiva"><i class="fa fa-check"></i><b>6.4.8</b> Dosering av antidepressiva</a></li>
<li class="chapter" data-level="6.4.9" data-path="depression.html"><a href="depression.html#effekt-på-enskilda-depressionssymtom"><i class="fa fa-check"></i><b>6.4.9</b> Effekt på enskilda depressionssymtom</a></li>
<li class="chapter" data-level="6.4.10" data-path="depression.html"><a href="depression.html#biverkningar-1"><i class="fa fa-check"></i><b>6.4.10</b> Biverkningar</a></li>
<li class="chapter" data-level="6.4.11" data-path="depression.html"><a href="depression.html#utsättningssymtom"><i class="fa fa-check"></i><b>6.4.11</b> Utsättningssymtom</a></li>
<li class="chapter" data-level="6.4.12" data-path="depression.html"><a href="depression.html#behandlingslängd"><i class="fa fa-check"></i><b>6.4.12</b> Behandlingslängd</a></li>
</ul></li>
<li class="chapter" data-level="6.5" data-path="depression.html"><a href="depression.html#depression-i-anslutning-till-förlossning"><i class="fa fa-check"></i><b>6.5</b> Depression i anslutning till förlossning</a></li>
<li class="chapter" data-level="6.6" data-path="depression.html"><a href="depression.html#depression-elderly"><i class="fa fa-check"></i><b>6.6</b> Depression hos äldre</a></li>
<li class="chapter" data-level="6.7" data-path="depression.html"><a href="depression.html#antidepressivas-effektivitet"><i class="fa fa-check"></i><b>6.7</b> Antidepressivas effektivitet</a></li>
<li class="chapter" data-level="6.8" data-path="depression.html"><a href="depression.html#indikationer"><i class="fa fa-check"></i><b>6.8</b> Indikationer</a>
<ul>
<li class="chapter" data-level="6.8.1" data-path="depression.html"><a href="depression.html#resurser-1"><i class="fa fa-check"></i><b>6.8.1</b> Resurser</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="7" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html"><i class="fa fa-check"></i><b>7</b> Bipolär sjukdom</a>
<ul>
<li class="chapter" data-level="7.1" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#inledning-2"><i class="fa fa-check"></i><b>7.1</b> Inledning</a>
<ul>
<li class="chapter" data-level="7.1.1" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#historik"><i class="fa fa-check"></i><b>7.1.1</b> Historik</a></li>
<li class="chapter" data-level="7.1.2" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#epiedmiologi"><i class="fa fa-check"></i><b>7.1.2</b> Epiedmiologi</a></li>
</ul></li>
<li class="chapter" data-level="7.2" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#diagnostik"><i class="fa fa-check"></i><b>7.2</b> Diagnostik</a>
<ul>
<li class="chapter" data-level="7.2.1" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#diagnostik-enligt-dsm"><i class="fa fa-check"></i><b>7.2.1</b> Diagnostik enligt DSM</a></li>
<li class="chapter" data-level="7.2.2" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#life-chart"><i class="fa fa-check"></i><b>7.2.2</b> Life chart</a></li>
<li class="chapter" data-level="7.2.3" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#prevalens-av-olika-symtom-vid-manisk-eller-blandad-episod"><i class="fa fa-check"></i><b>7.2.3</b> Prevalens av olika symtom vid manisk eller blandad episod</a></li>
<li class="chapter" data-level="7.2.4" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#bipolär-i-vs-bipolär-ii"><i class="fa fa-check"></i><b>7.2.4</b> Bipolär I vs Bipolär II</a></li>
<li class="chapter" data-level="7.2.5" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#när-misstänka-bipolärt-syndrom-vid-depressioner"><i class="fa fa-check"></i><b>7.2.5</b> När misstänka bipolärt syndrom vid depressioner?</a></li>
<li class="chapter" data-level="7.2.6" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#screening-för-bipolärt-syndrom-vid-misstanke"><i class="fa fa-check"></i><b>7.2.6</b> Screening för bipolärt syndrom vid misstanke</a></li>
<li class="chapter" data-level="7.2.7" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#kartläggning-av-förlopp-symtom-mm"><i class="fa fa-check"></i><b>7.2.7</b> Kartläggning av förlopp, symtom mm</a></li>
<li class="chapter" data-level="7.2.8" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#samsjuklighet"><i class="fa fa-check"></i><b>7.2.8</b> Samsjuklighet</a></li>
<li class="chapter" data-level="7.2.9" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#differentialdiagnostik-vid-mani"><i class="fa fa-check"></i><b>7.2.9</b> Differentialdiagnostik vid mani</a></li>
<li class="chapter" data-level="7.2.10" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#differential-psychiatric"><i class="fa fa-check"></i><b>7.2.10</b> Differentiera mot andra psykiatriska tillstånd</a></li>
<li class="chapter" data-level="7.2.11" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#psykos-vid-bipolärt-syndrom"><i class="fa fa-check"></i><b>7.2.11</b> Psykos vid bipolärt syndrom</a></li>
</ul></li>
<li class="chapter" data-level="7.3" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#behandling-1"><i class="fa fa-check"></i><b>7.3</b> Behandling</a>
<ul>
<li class="chapter" data-level="7.3.1" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#behandling-enligt-olika-riktlinjer"><i class="fa fa-check"></i><b>7.3.1</b> Behandling enligt olika riktlinjer</a></li>
<li class="chapter" data-level="7.3.2" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#behandling-tumregler"><i class="fa fa-check"></i><b>7.3.2</b> Behandling tumregler</a></li>
<li class="chapter" data-level="7.3.3" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#val-av-behandling-enligt-canmat-2018"><i class="fa fa-check"></i><b>7.3.3</b> Val av behandling enligt CANMAT 2018</a></li>
<li class="chapter" data-level="7.3.4" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#behandling-av-manisk-episod"><i class="fa fa-check"></i><b>7.3.4</b> Behandling av manisk episod</a></li>
<li class="chapter" data-level="7.3.5" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#behandling-av-bipolär-depression"><i class="fa fa-check"></i><b>7.3.5</b> Behandling av bipolär depression</a></li>
<li class="chapter" data-level="7.3.6" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#treatment-factors-prevention"><i class="fa fa-check"></i><b>7.3.6</b> Underhållsbehandling</a></li>
<li class="chapter" data-level="7.3.7" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#medications-bipolar"><i class="fa fa-check"></i><b>7.3.7</b> Läkemedel vid bipolärt syndrom</a></li>
<li class="chapter" data-level="7.3.8" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#bipolär-typ-ii---behandling"><i class="fa fa-check"></i><b>7.3.8</b> Bipolär typ II - behandling</a></li>
<li class="chapter" data-level="7.3.9" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#psykosociala-interventioner"><i class="fa fa-check"></i><b>7.3.9</b> Psykosociala interventioner</a></li>
</ul></li>
<li class="chapter" data-level="7.4" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#skattningsinstrument"><i class="fa fa-check"></i><b>7.4</b> Skattningsinstrument</a>
<ul>
<li class="chapter" data-level="7.4.1" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#hcl-32"><i class="fa fa-check"></i><b>7.4.1</b> HCL-32</a></li>
</ul></li>
<li class="chapter" data-level="7.5" data-path="bipolär-sjukdom.html"><a href="bipolär-sjukdom.html#resources"><i class="fa fa-check"></i><b>7.5</b> Resources</a></li>
</ul></li>
<li class="chapter" data-level="8" data-path="ångest.html"><a href="ångest.html"><i class="fa fa-check"></i><b>8</b> Ångest</a>
<ul>
<li class="chapter" data-level="8.1" data-path="ångest.html"><a href="ångest.html#läkemedelsbehandling-2"><i class="fa fa-check"></i><b>8.1</b> Läkemedelsbehandling</a></li>
<li class="chapter" data-level="8.2" data-path="ångest.html"><a href="ångest.html#ångestsyndrom-hos-barn"><i class="fa fa-check"></i><b>8.2</b> Ångestsyndrom hos barn</a></li>
</ul></li>
<li class="chapter" data-level="9" data-path="adhd.html"><a href="adhd.html"><i class="fa fa-check"></i><b>9</b> ADHD</a>
<ul>
<li class="chapter" data-level="9.1" data-path="adhd.html"><a href="adhd.html#differentialdiagnostik"><i class="fa fa-check"></i><b>9.1</b> Differentialdiagnostik</a></li>
<li class="chapter" data-level="9.2" data-path="adhd.html"><a href="adhd.html#samsjuklighet-1"><i class="fa fa-check"></i><b>9.2</b> Samsjuklighet</a></li>
<li class="chapter" data-level="9.3" data-path="adhd.html"><a href="adhd.html#bedömning-inför-mottagande-i-adhd-team-remisskrav"><i class="fa fa-check"></i><b>9.3</b> Bedömning inför mottagande i ADHD-team (remisskrav)</a></li>
<li class="chapter" data-level="9.4" data-path="adhd.html"><a href="adhd.html#screening-inom-psykiatrin"><i class="fa fa-check"></i><b>9.4</b> Screening inom psykiatrin</a>
<ul>
<li class="chapter" data-level="9.4.1" data-path="adhd.html"><a href="adhd.html#aktuella-dokumentverktyg-för-screening-som-kan-användas-under-hela-utredningsförloppet"><i class="fa fa-check"></i><b>9.4.1</b> Aktuella dokument/verktyg för screening som kan användas under hela utredningsförloppet</a></li>
</ul></li>
<li class="chapter" data-level="9.5" data-path="adhd.html"><a href="adhd.html#bedömning-inom-psykiatrin"><i class="fa fa-check"></i><b>9.5</b> Bedömning inom psykiatrin</a>
<ul>
<li class="chapter" data-level="9.5.1" data-path="adhd.html"><a href="adhd.html#bedömningssamtalsmall"><i class="fa fa-check"></i><b>9.5.1</b> Bedömningssamtalsmall</a></li>
</ul></li>
<li class="chapter" data-level="9.6" data-path="adhd.html"><a href="adhd.html#bedömning-inför-läkemedelsbehandling"><i class="fa fa-check"></i><b>9.6</b> Bedömning inför läkemedelsbehandling</a>
<ul>
<li class="chapter" data-level="9.6.1" data-path="adhd.html"><a href="adhd.html#ökad-kardiell-risk-vid"><i class="fa fa-check"></i><b>9.6.1</b> Ökad kardiell risk vid…</a></li>
</ul></li>
<li class="chapter" data-level="9.7" data-path="adhd.html"><a href="adhd.html#uppföljning"><i class="fa fa-check"></i><b>9.7</b> Uppföljning</a></li>
<li class="chapter" data-level="9.8" data-path="adhd.html"><a href="adhd.html#särskild-observans"><i class="fa fa-check"></i><b>9.8</b> Särskild observans</a></li>
<li class="chapter" data-level="9.9" data-path="adhd.html"><a href="adhd.html#adhd-medication"><i class="fa fa-check"></i><b>9.9</b> Läkemedel för ADHD</a></li>
<li class="chapter" data-level="9.10" data-path="adhd.html"><a href="adhd.html#psykopedagogiska-insatser"><i class="fa fa-check"></i><b>9.10</b> Psykopedagogiska insatser</a></li>
<li class="chapter" data-level="9.11" data-path="adhd.html"><a href="adhd.html#psykologisk-behandling"><i class="fa fa-check"></i><b>9.11</b> Psykologisk behandling</a></li>
<li class="chapter" data-level="9.12" data-path="adhd.html"><a href="adhd.html#arbetsterapeutiska-behandlingsinsatser"><i class="fa fa-check"></i><b>9.12</b> Arbetsterapeutiska behandlingsinsatser</a></li>
<li class="chapter" data-level="9.13" data-path="adhd.html"><a href="adhd.html#kuratorsbehandling"><i class="fa fa-check"></i><b>9.13</b> Kuratorsbehandling</a></li>
<li class="chapter" data-level="9.14" data-path="adhd.html"><a href="adhd.html#vårdplan"><i class="fa fa-check"></i><b>9.14</b> Vårdplan</a></li>
</ul></li>
<li class="chapter" data-level="10" data-path="autism.html"><a href="autism.html"><i class="fa fa-check"></i><b>10</b> Autism</a>
<ul>
<li class="chapter" data-level="10.1" data-path="autism.html"><a href="autism.html#kliniska-tecken"><i class="fa fa-check"></i><b>10.1</b> Kliniska tecken</a>
<ul>
<li class="chapter" data-level="10.1.1" data-path="autism.html"><a href="autism.html#essence"><i class="fa fa-check"></i><b>10.1.1</b> ESSENCE</a></li>
</ul></li>
<li class="chapter" data-level="10.2" data-path="autism.html"><a href="autism.html#epidemiologi-1"><i class="fa fa-check"></i><b>10.2</b> Epidemiologi</a></li>
<li class="chapter" data-level="10.3" data-path="autism.html"><a href="autism.html#konsekvenser"><i class="fa fa-check"></i><b>10.3</b> Konsekvenser</a></li>
<li class="chapter" data-level="10.4" data-path="autism.html"><a href="autism.html#differentialdiagnos"><i class="fa fa-check"></i><b>10.4</b> Differentialdiagnos</a></li>
<li class="chapter" data-level="10.5" data-path="autism.html"><a href="autism.html#samsjuklighet-2"><i class="fa fa-check"></i><b>10.5</b> Samsjuklighet</a></li>
<li class="chapter" data-level="10.6" data-path="autism.html"><a href="autism.html#utredning"><i class="fa fa-check"></i><b>10.6</b> Utredning</a>
<ul>
<li class="chapter" data-level="10.6.1" data-path="autism.html"><a href="autism.html#psykiatrisk-anamnes"><i class="fa fa-check"></i><b>10.6.1</b> Psykiatrisk anamnes</a></li>
<li class="chapter" data-level="10.6.2" data-path="autism.html"><a href="autism.html#psykiskt-status"><i class="fa fa-check"></i><b>10.6.2</b> Psykiskt status</a></li>
<li class="chapter" data-level="10.6.3" data-path="autism.html"><a href="autism.html#somatisk-anamnes-och-status"><i class="fa fa-check"></i><b>10.6.3</b> Somatisk anamnes och status</a></li>
<li class="chapter" data-level="10.6.4" data-path="autism.html"><a href="autism.html#neuropsykologisk-testning"><i class="fa fa-check"></i><b>10.6.4</b> Neuropsykologisk testning</a></li>
<li class="chapter" data-level="10.6.5" data-path="autism.html"><a href="autism.html#uppföljning-1"><i class="fa fa-check"></i><b>10.6.5</b> Uppföljning</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="11" data-path="sleep-physiology.html"><a href="sleep-physiology.html"><i class="fa fa-check"></i><b>11</b> Sömn</a>
<ul>
<li class="chapter" data-level="11.1" data-path="sleep-physiology.html"><a href="sleep-physiology.html#inledning-3"><i class="fa fa-check"></i><b>11.1</b> Inledning</a></li>
<li class="chapter" data-level="11.2" data-path="sleep-physiology.html"><a href="sleep-physiology.html#modell-för-reglering-av-sömn-och-vakenhet"><i class="fa fa-check"></i><b>11.2</b> Modell för reglering av sömn och vakenhet</a></li>
<li class="chapter" data-level="11.3" data-path="sleep-physiology.html"><a href="sleep-physiology.html#diverse"><i class="fa fa-check"></i><b>11.3</b> Diverse</a></li>
<li class="chapter" data-level="11.4" data-path="sleep-physiology.html"><a href="sleep-physiology.html#parasomnier"><i class="fa fa-check"></i><b>11.4</b> Parasomnier</a></li>
<li class="chapter" data-level="11.5" data-path="sleep-physiology.html"><a href="sleep-physiology.html#sömnhygien"><i class="fa fa-check"></i><b>11.5</b> Sömnhygien</a></li>
<li class="chapter" data-level="11.6" data-path="sleep-physiology.html"><a href="sleep-physiology.html#läkemedelsbehandling-3"><i class="fa fa-check"></i><b>11.6</b> Läkemedelsbehandling</a></li>
</ul></li>
<li class="chapter" data-level="12" data-path="basal-ganglia.html"><a href="basal-ganglia.html"><i class="fa fa-check"></i><b>12</b> De basala ganglierna</a>
<ul>
<li class="chapter" data-level="12.1" data-path="basal-ganglia.html"><a href="basal-ganglia.html#striatum"><i class="fa fa-check"></i><b>12.1</b> Striatum</a></li>
<li class="chapter" data-level="12.2" data-path="basal-ganglia.html"><a href="basal-ganglia.html#den-direkta-och-indirekta-banan"><i class="fa fa-check"></i><b>12.2</b> Den direkta och indirekta banan</a></li>
<li class="chapter" data-level="12.3" data-path="basal-ganglia.html"><a href="basal-ganglia.html#pallidum"><i class="fa fa-check"></i><b>12.3</b> Pallidum</a></li>
<li class="chapter" data-level="12.4" data-path="basal-ganglia.html"><a href="basal-ganglia.html#substantia-nigra-och-globus-pallidus-interna"><i class="fa fa-check"></i><b>12.4</b> Substantia nigra och globus pallidus interna</a></li>
<li class="chapter" data-level="12.5" data-path="basal-ganglia.html"><a href="basal-ganglia.html#globus-pallidus-externa"><i class="fa fa-check"></i><b>12.5</b> Globus pallidus externa</a></li>
<li class="chapter" data-level="12.6" data-path="basal-ganglia.html"><a href="basal-ganglia.html#subthalamuskärnan"><i class="fa fa-check"></i><b>12.6</b> Subthalamuskärnan</a></li>
<li class="chapter" data-level="12.7" data-path="basal-ganglia.html"><a href="basal-ganglia.html#signalsubstanser-i-de-basala-ganglierna"><i class="fa fa-check"></i><b>12.7</b> Signalsubstanser i de basala ganglierna</a></li>
<li class="chapter" data-level="12.8" data-path="basal-ganglia.html"><a href="basal-ganglia.html#basala-gangliernas-funktion"><i class="fa fa-check"></i><b>12.8</b> Basala gangliernas funktion</a></li>
<li class="chapter" data-level="12.9" data-path="basal-ganglia.html"><a href="basal-ganglia.html#nigrostriatala-banan"><i class="fa fa-check"></i><b>12.9</b> Nigrostriatala banan</a></li>
<li class="chapter" data-level="12.10" data-path="basal-ganglia.html"><a href="basal-ganglia.html#mesostriatala-banan"><i class="fa fa-check"></i><b>12.10</b> Mesostriatala banan</a></li>
<li class="chapter" data-level="12.11" data-path="basal-ganglia.html"><a href="basal-ganglia.html#mesolimbiska-banan"><i class="fa fa-check"></i><b>12.11</b> Mesolimbiska banan</a></li>
<li class="chapter" data-level="12.12" data-path="basal-ganglia.html"><a href="basal-ganglia.html#lista-över-de-basala-ganglierna-och-relaterade-kärnor"><i class="fa fa-check"></i><b>12.12</b> Lista över de basala ganglierna och relaterade kärnor</a>
<ul>
<li class="chapter" data-level="12.12.1" data-path="basal-ganglia.html"><a href="basal-ganglia.html#lista-över-nervbanor"><i class="fa fa-check"></i><b>12.12.1</b> Lista över nervbanor</a></li>
<li class="chapter" data-level="12.12.2" data-path="basal-ganglia.html"><a href="basal-ganglia.html#funktioner-relaterade-till-de-basala-ganglierna"><i class="fa fa-check"></i><b>12.12.2</b> Funktioner relaterade till de basala ganglierna</a></li>
<li class="chapter" data-level="12.12.3" data-path="basal-ganglia.html"><a href="basal-ganglia.html#sjukdomar-och-symtom-vid-störd-funktion-i-basala-ganglierna"><i class="fa fa-check"></i><b>12.12.3</b> Sjukdomar och symtom vid störd funktion i basala ganglierna</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="13" data-path="autonoma-nervsystemet.html"><a href="autonoma-nervsystemet.html"><i class="fa fa-check"></i><b>13</b> Autonoma nervsystemet</a>
<ul>
<li class="chapter" data-level="13.0.1" data-path="autonoma-nervsystemet.html"><a href="autonoma-nervsystemet.html#referenser-1"><i class="fa fa-check"></i><b>13.0.1</b> Referenser</a></li>
</ul></li>
<li class="chapter" data-level="14" data-path="neuroendokrinologi.html"><a href="neuroendokrinologi.html"><i class="fa fa-check"></i><b>14</b> Neuroendokrinologi</a>
<ul>
<li class="chapter" data-level="14.1" data-path="neuroendokrinologi.html"><a href="neuroendokrinologi.html#resurser-2"><i class="fa fa-check"></i><b>14.1</b> Resurser</a></li>
</ul></li>
<li class="chapter" data-level="15" data-path="psychopharmacology.html"><a href="psychopharmacology.html"><i class="fa fa-check"></i><b>15</b> Psykofarmakologi</a>
<ul>
<li class="chapter" data-level="15.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#allmänna-principer"><i class="fa fa-check"></i><b>15.1</b> Allmänna principer</a></li>
<li class="chapter" data-level="15.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#metabolism-av-psykotropa-läkemedel"><i class="fa fa-check"></i><b>15.2</b> Metabolism av psykotropa läkemedel</a></li>
<li class="chapter" data-level="15.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#mätning-av-plasmakoncentrationer"><i class="fa fa-check"></i><b>15.3</b> Mätning av plasmakoncentrationer</a>
<ul>
<li class="chapter" data-level="15.3.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#antidepressiva"><i class="fa fa-check"></i><b>15.3.1</b> Antidepressiva</a></li>
<li class="chapter" data-level="15.3.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#antipsykotiska-medel"><i class="fa fa-check"></i><b>15.3.2</b> Antipsykotiska medel</a></li>
<li class="chapter" data-level="15.3.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#läkemedel-vid-bipolärt-syndrom"><i class="fa fa-check"></i><b>15.3.3</b> Läkemedel vid bipolärt syndrom</a></li>
</ul></li>
<li class="chapter" data-level="15.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#ssri-pregnancy"><i class="fa fa-check"></i><b>15.4</b> SSRI vid graviditet och amning</a>
<ul>
<li class="chapter" data-level="15.4.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#risker-för-barnet"><i class="fa fa-check"></i><b>15.4.1</b> Risker för barnet</a></li>
<li class="chapter" data-level="15.4.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#risker-för-mamman"><i class="fa fa-check"></i><b>15.4.2</b> Risker för mamman</a></li>
<li class="chapter" data-level="15.4.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#utsöndring-av-ssri-i-bröstmjölk"><i class="fa fa-check"></i><b>15.4.3</b> Utsöndring av SSRI i bröstmjölk</a></li>
<li class="chapter" data-level="15.4.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#resurser-3"><i class="fa fa-check"></i><b>15.4.4</b> Resurser</a></li>
</ul></li>
<li class="chapter" data-level="15.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#antidepressant-meds"><i class="fa fa-check"></i><b>15.5</b> Antidepressiva läkemedel</a>
<ul>
<li class="chapter" data-level="15.5.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#likheter-bland-de-flesta-antidepressiva"><i class="fa fa-check"></i><b>15.5.1</b> Likheter bland de flesta antidepressiva</a></li>
<li class="chapter" data-level="15.5.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#olikheter-i-receptorprofil"><i class="fa fa-check"></i><b>15.5.2</b> Olikheter i receptorprofil</a></li>
<li class="chapter" data-level="15.5.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#finns-dos-respons"><i class="fa fa-check"></i><b>15.5.3</b> Finns dos-respons?</a></li>
<li class="chapter" data-level="15.5.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#tricykliska-antidepressiva"><i class="fa fa-check"></i><b>15.5.4</b> Tricykliska antidepressiva</a></li>
<li class="chapter" data-level="15.5.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#bupropion"><i class="fa fa-check"></i><b>15.5.5</b> Bupropion</a></li>
</ul></li>
<li class="chapter" data-level="15.6" data-path="psychopharmacology.html"><a href="psychopharmacology.html#antipsychotics"><i class="fa fa-check"></i><b>15.6</b> Antipsykotiska läkemedel</a>
<ul>
<li class="chapter" data-level="15.6.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#receptoraffinitet"><i class="fa fa-check"></i><b>15.6.1</b> Receptoraffinitet</a></li>
<li class="chapter" data-level="15.6.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#doseringsintervall"><i class="fa fa-check"></i><b>15.6.2</b> Doseringsintervall</a></li>
<li class="chapter" data-level="15.6.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#biverkningar-översikt"><i class="fa fa-check"></i><b>15.6.3</b> Biverkningar översikt</a></li>
<li class="chapter" data-level="15.6.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#motoriska-biverkningar"><i class="fa fa-check"></i><b>15.6.4</b> Motoriska biverkningar</a></li>
<li class="chapter" data-level="15.6.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#metabola-biverkningar"><i class="fa fa-check"></i><b>15.6.5</b> Metabola biverkningar</a></li>
<li class="chapter" data-level="15.6.6" data-path="psychopharmacology.html"><a href="psychopharmacology.html#hematologiska-biverkningar"><i class="fa fa-check"></i><b>15.6.6</b> Hematologiska biverkningar</a></li>
<li class="chapter" data-level="15.6.7" data-path="psychopharmacology.html"><a href="psychopharmacology.html#olika-typer-av-antipsykotiska-läkemedel"><i class="fa fa-check"></i><b>15.6.7</b> Olika typer av antipsykotiska läkemedel</a></li>
<li class="chapter" data-level="15.6.8" data-path="psychopharmacology.html"><a href="psychopharmacology.html#kombinationsbehandling-1"><i class="fa fa-check"></i><b>15.6.8</b> Kombinationsbehandling</a></li>
<li class="chapter" data-level="15.6.9" data-path="psychopharmacology.html"><a href="psychopharmacology.html#switching"><i class="fa fa-check"></i><b>15.6.9</b> Switching</a></li>
</ul></li>
<li class="chapter" data-level="15.7" data-path="psychopharmacology.html"><a href="psychopharmacology.html#psykotropa-läkemedel-vid-leverpåverkan"><i class="fa fa-check"></i><b>15.7</b> Psykotropa läkemedel vid leverpåverkan</a>
<ul>
<li class="chapter" data-level="15.7.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#anpassning-av-läkemedelsdoser"><i class="fa fa-check"></i><b>15.7.1</b> Anpassning av läkemedelsdoser</a></li>
<li class="chapter" data-level="15.7.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#leverpåverkan-från-psykotropa-läkemedel"><i class="fa fa-check"></i><b>15.7.2</b> Leverpåverkan från psykotropa läkemedel</a></li>
</ul></li>
<li class="chapter" data-level="15.8" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lithium"><i class="fa fa-check"></i><b>15.8</b> Litium</a>
<ul>
<li class="chapter" data-level="15.8.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#effekt-av-litium-vid-bdulrichsen2023"><i class="fa fa-check"></i><b>15.8.1</b> Effekt av litium vid BD<span class="citation">[121]</span></a></li>
<li class="chapter" data-level="15.8.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#historik-1"><i class="fa fa-check"></i><b>15.8.2</b> Historik</a></li>
<li class="chapter" data-level="15.8.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#indikationer-1"><i class="fa fa-check"></i><b>15.8.3</b> Indikationer</a></li>
<li class="chapter" data-level="15.8.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#biverkningar-2"><i class="fa fa-check"></i><b>15.8.4</b> Biverkningar</a></li>
<li class="chapter" data-level="15.8.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#farmakokinetik"><i class="fa fa-check"></i><b>15.8.5</b> Farmakokinetik</a></li>
<li class="chapter" data-level="15.8.6" data-path="psychopharmacology.html"><a href="psychopharmacology.html#dosering-i-praktiken"><i class="fa fa-check"></i><b>15.8.6</b> Dosering i praktiken</a></li>
<li class="chapter" data-level="15.8.7" data-path="psychopharmacology.html"><a href="psychopharmacology.html#mer-om-litiumkoncentration"><i class="fa fa-check"></i><b>15.8.7</b> Mer om litiumkoncentration</a></li>
<li class="chapter" data-level="15.8.8" data-path="psychopharmacology.html"><a href="psychopharmacology.html#monitorering-1"><i class="fa fa-check"></i><b>15.8.8</b> Monitorering</a></li>
<li class="chapter" data-level="15.8.9" data-path="psychopharmacology.html"><a href="psychopharmacology.html#biverkningar-3"><i class="fa fa-check"></i><b>15.8.9</b> Biverkningar</a></li>
<li class="chapter" data-level="15.8.10" data-path="psychopharmacology.html"><a href="psychopharmacology.html#toxicitet"><i class="fa fa-check"></i><b>15.8.10</b> Toxicitet</a></li>
</ul></li>
<li class="chapter" data-level="15.9" data-path="psychopharmacology.html"><a href="psychopharmacology.html#clozapine"><i class="fa fa-check"></i><b>15.9</b> Klozapin</a>
<ul>
<li class="chapter" data-level="15.9.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#inledning-4"><i class="fa fa-check"></i><b>15.9.1</b> Inledning</a></li>
<li class="chapter" data-level="15.9.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#behandlingsresistent-schizofreni"><i class="fa fa-check"></i><b>15.9.2</b> Behandlingsresistent schizofreni</a></li>
<li class="chapter" data-level="15.9.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#psykogen-polydipsi"><i class="fa fa-check"></i><b>15.9.3</b> Psykogen polydipsi</a></li>
<li class="chapter" data-level="15.9.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#aggressivitet"><i class="fa fa-check"></i><b>15.9.4</b> Aggressivitet</a></li>
<li class="chapter" data-level="15.9.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#behandlingsresistent-mani"><i class="fa fa-check"></i><b>15.9.5</b> Behandlingsresistent mani</a></li>
<li class="chapter" data-level="15.9.6" data-path="psychopharmacology.html"><a href="psychopharmacology.html#psykos-vid-parkinsons-sjukdom"><i class="fa fa-check"></i><b>15.9.6</b> Psykos vid Parkinsons sjukdom</a></li>
<li class="chapter" data-level="15.9.7" data-path="psychopharmacology.html"><a href="psychopharmacology.html#kontroller-vid-baslinje"><i class="fa fa-check"></i><b>15.9.7</b> Kontroller vid baslinje</a></li>
<li class="chapter" data-level="15.9.8" data-path="psychopharmacology.html"><a href="psychopharmacology.html#monitorering-under-behandling"><i class="fa fa-check"></i><b>15.9.8</b> Monitorering under behandling</a></li>
<li class="chapter" data-level="15.9.9" data-path="psychopharmacology.html"><a href="psychopharmacology.html#titrering"><i class="fa fa-check"></i><b>15.9.9</b> Titrering</a></li>
<li class="chapter" data-level="15.9.10" data-path="psychopharmacology.html"><a href="psychopharmacology.html#serumkoncentrationer"><i class="fa fa-check"></i><b>15.9.10</b> Serumkoncentrationer</a></li>
<li class="chapter" data-level="15.9.11" data-path="psychopharmacology.html"><a href="psychopharmacology.html#biverkningar-av-klozapin"><i class="fa fa-check"></i><b>15.9.11</b> Biverkningar av klozapin</a></li>
</ul></li>
<li class="chapter" data-level="15.10" data-path="psychopharmacology.html"><a href="psychopharmacology.html#sleep-meds"><i class="fa fa-check"></i><b>15.10</b> Sömnmedel</a>
<ul>
<li class="chapter" data-level="15.10.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#bensodiazepiner-som-sömnmedel"><i class="fa fa-check"></i><b>15.10.1</b> Bensodiazepiner som sömnmedel</a></li>
<li class="chapter" data-level="15.10.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#bensodiazepinliknande-medel"><i class="fa fa-check"></i><b>15.10.2</b> Bensodiazepinliknande medel</a></li>
<li class="chapter" data-level="15.10.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#melatoninreceptoragonister"><i class="fa fa-check"></i><b>15.10.3</b> Melatoninreceptoragonister</a></li>
<li class="chapter" data-level="15.10.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#ickeselektiva-antihistaminer"><i class="fa fa-check"></i><b>15.10.4</b> Ickeselektiva antihistaminer</a></li>
<li class="chapter" data-level="15.10.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#antidepressiva-som-sömnmedel"><i class="fa fa-check"></i><b>15.10.5</b> Antidepressiva som sömnmedel</a></li>
<li class="chapter" data-level="15.10.6" data-path="psychopharmacology.html"><a href="psychopharmacology.html#antipsykotiska-som-sömnmedel"><i class="fa fa-check"></i><b>15.10.6</b> Antipsykotiska som sömnmedel</a></li>
<li class="chapter" data-level="15.10.7" data-path="psychopharmacology.html"><a href="psychopharmacology.html#andra"><i class="fa fa-check"></i><b>15.10.7</b> Andra</a></li>
<li class="chapter" data-level="15.10.8" data-path="psychopharmacology.html"><a href="psychopharmacology.html#kbt-i"><i class="fa fa-check"></i><b>15.10.8</b> KBT-I</a></li>
</ul></li>
<li class="chapter" data-level="15.11" data-path="psychopharmacology.html"><a href="psychopharmacology.html#bensodiazepiner"><i class="fa fa-check"></i><b>15.11</b> Bensodiazepiner</a></li>
<li class="chapter" data-level="15.12" data-path="psychopharmacology.html"><a href="psychopharmacology.html#ketamin"><i class="fa fa-check"></i><b>15.12</b> Ketamin</a>
<ul>
<li class="chapter" data-level="15.12.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#indikationer-2"><i class="fa fa-check"></i><b>15.12.1</b> Indikationer</a></li>
<li class="chapter" data-level="15.12.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#biverkningar-4"><i class="fa fa-check"></i><b>15.12.2</b> Biverkningar</a></li>
<li class="chapter" data-level="15.12.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#vetenskapligt-stöd"><i class="fa fa-check"></i><b>15.12.3</b> Vetenskapligt stöd</a></li>
<li class="chapter" data-level="15.12.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#praktiskt-genomförande-av-ketamininfusion"><i class="fa fa-check"></i><b>15.12.4</b> Praktiskt genomförande av ketamininfusion</a></li>
</ul></li>
<li class="chapter" data-level="15.13" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin"><i class="fa fa-check"></i><b>15.13</b> Lamotrigin</a>
<ul>
<li class="chapter" data-level="15.13.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-vid-akut-bp-depression"><i class="fa fa-check"></i><b>15.13.1</b> Lamotrigin vid akut BP depression?</a></li>
<li class="chapter" data-level="15.13.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-profylax-vid-bipolärt-syndrom"><i class="fa fa-check"></i><b>15.13.2</b> Lamotrigin profylax vid bipolärt syndrom?</a></li>
<li class="chapter" data-level="15.13.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-prevention-bd-episod"><i class="fa fa-check"></i><b>15.13.3</b> Lamotrigin prevention BD episod</a></li>
<li class="chapter" data-level="15.13.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-prevention-bd-depression"><i class="fa fa-check"></i><b>15.13.4</b> Lamotrigin prevention BD depression</a></li>
<li class="chapter" data-level="15.13.5" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-prevention-bd-mani"><i class="fa fa-check"></i><b>15.13.5</b> Lamotrigin prevention BD mani</a></li>
<li class="chapter" data-level="15.13.6" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-vid-akut-mdd"><i class="fa fa-check"></i><b>15.13.6</b> Lamotrigin vid akut MDD</a></li>
<li class="chapter" data-level="15.13.7" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-profylax-mdd"><i class="fa fa-check"></i><b>15.13.7</b> Lamotrigin profylax MDD</a></li>
<li class="chapter" data-level="15.13.8" data-path="psychopharmacology.html"><a href="psychopharmacology.html#sammanfattning-lamotrigin-vid-affektiva-syndrom"><i class="fa fa-check"></i><b>15.13.8</b> Sammanfattning lamotrigin vid affektiva syndrom</a></li>
<li class="chapter" data-level="15.13.9" data-path="psychopharmacology.html"><a href="psychopharmacology.html#sammanfattning-ungefärlig-effektstorlek"><i class="fa fa-check"></i><b>15.13.9</b> Sammanfattning ungefärlig effektstorlek</a></li>
<li class="chapter" data-level="15.13.10" data-path="psychopharmacology.html"><a href="psychopharmacology.html#guidelines-lamotrigin-vid-bp"><i class="fa fa-check"></i><b>15.13.10</b> Guidelines lamotrigin vid BP</a></li>
<li class="chapter" data-level="15.13.11" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-vid-eips"><i class="fa fa-check"></i><b>15.13.11</b> Lamotrigin vid EIPS</a></li>
<li class="chapter" data-level="15.13.12" data-path="psychopharmacology.html"><a href="psychopharmacology.html#biverkningar-av-lamotrigin"><i class="fa fa-check"></i><b>15.13.12</b> Biverkningar av lamotrigin</a></li>
<li class="chapter" data-level="15.13.13" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-hudutslag"><i class="fa fa-check"></i><b>15.13.13</b> Lamotrigin hudutslag</a></li>
<li class="chapter" data-level="15.13.14" data-path="psychopharmacology.html"><a href="psychopharmacology.html#lamotrigin-titrering"><i class="fa fa-check"></i><b>15.13.14</b> Lamotrigin titrering</a></li>
<li class="chapter" data-level="15.13.15" data-path="psychopharmacology.html"><a href="psychopharmacology.html#resurser-lamotrigin"><i class="fa fa-check"></i><b>15.13.15</b> Resurser lamotrigin</a></li>
</ul></li>
<li class="chapter" data-level="15.14" data-path="psychopharmacology.html"><a href="psychopharmacology.html#vissa-biverkningar-av-psykofarmaka"><i class="fa fa-check"></i><b>15.14</b> Vissa biverkningar av psykofarmaka</a>
<ul>
<li class="chapter" data-level="15.14.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#arytmirisk"><i class="fa fa-check"></i><b>15.14.1</b> Arytmirisk</a></li>
<li class="chapter" data-level="15.14.2" data-path="psychopharmacology.html"><a href="psychopharmacology.html#side-effects-anticholinergic"><i class="fa fa-check"></i><b>15.14.2</b> Antikolinerga biverkningar</a></li>
<li class="chapter" data-level="15.14.3" data-path="psychopharmacology.html"><a href="psychopharmacology.html#hudbiverkningar"><i class="fa fa-check"></i><b>15.14.3</b> Hudbiverkningar</a></li>
<li class="chapter" data-level="15.14.4" data-path="psychopharmacology.html"><a href="psychopharmacology.html#inverkan-på-kramptröskel"><i class="fa fa-check"></i><b>15.14.4</b> Inverkan på kramptröskel</a></li>
</ul></li>
<li class="chapter" data-level="15.15" data-path="psychopharmacology.html"><a href="psychopharmacology.html#beskrivning-av-vissa-läkemedel"><i class="fa fa-check"></i><b>15.15</b> Beskrivning av vissa läkemedel</a></li>
<li class="chapter" data-level="15.16" data-path="psychopharmacology.html"><a href="psychopharmacology.html#beskrivning-av-vissa-biverkningar"><i class="fa fa-check"></i><b>15.16</b> Beskrivning av vissa biverkningar</a>
<ul>
<li class="chapter" data-level="15.16.1" data-path="psychopharmacology.html"><a href="psychopharmacology.html#psykofarmakologi-tdp"><i class="fa fa-check"></i><b>15.16.1</b> TdP</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="16" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html"><i class="fa fa-check"></i><b>16</b> Elektrokonvulsiv terapi</a>
<ul>
<li class="chapter" data-level="16.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#ect-introduction"><i class="fa fa-check"></i><b>16.1</b> Inledning</a></li>
<li class="chapter" data-level="16.2" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#ect-indications"><i class="fa fa-check"></i><b>16.2</b> Indikationer</a>
<ul>
<li class="chapter" data-level="16.2.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#kontraindikationer-och-riskvärdering"><i class="fa fa-check"></i><b>16.2.1</b> Kontraindikationer och riskvärdering</a></li>
<li class="chapter" data-level="16.2.2" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#depression-1"><i class="fa fa-check"></i><b>16.2.2</b> Depression</a></li>
<li class="chapter" data-level="16.2.3" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#mani"><i class="fa fa-check"></i><b>16.2.3</b> Mani</a></li>
<li class="chapter" data-level="16.2.4" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#psykos"><i class="fa fa-check"></i><b>16.2.4</b> Psykos</a></li>
<li class="chapter" data-level="16.2.5" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#katatoni-1"><i class="fa fa-check"></i><b>16.2.5</b> Katatoni</a></li>
<li class="chapter" data-level="16.2.6" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#övriga-tillstånd-som-kan-behandlas-med-ect"><i class="fa fa-check"></i><b>16.2.6</b> Övriga tillstånd som kan behandlas med ECT</a></li>
<li class="chapter" data-level="16.2.7" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#överväganden"><i class="fa fa-check"></i><b>16.2.7</b> Överväganden</a></li>
<li class="chapter" data-level="16.2.8" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#ect-vid-graviditet-och-amning"><i class="fa fa-check"></i><b>16.2.8</b> ECT vid graviditet och amning</a></li>
<li class="chapter" data-level="16.2.9" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#ect-för-barn"><i class="fa fa-check"></i><b>16.2.9</b> ECT för barn</a></li>
</ul></li>
<li class="chapter" data-level="16.3" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#effektivitet"><i class="fa fa-check"></i><b>16.3</b> Effektivitet</a></li>
<li class="chapter" data-level="16.4" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#ect-side-effects"><i class="fa fa-check"></i><b>16.4</b> Biverkningar</a>
<ul>
<li class="chapter" data-level="16.4.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#konfusion-i-anslutning-till-behandlingen"><i class="fa fa-check"></i><b>16.4.1</b> Konfusion i anslutning till behandlingen</a></li>
<li class="chapter" data-level="16.4.2" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#minnesproblem"><i class="fa fa-check"></i><b>16.4.2</b> Minnesproblem</a></li>
<li class="chapter" data-level="16.4.3" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#postiktal-agitation"><i class="fa fa-check"></i><b>16.4.3</b> Postiktal agitation</a></li>
<li class="chapter" data-level="16.4.4" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#minnesproblem-1"><i class="fa fa-check"></i><b>16.4.4</b> Minnesproblem</a></li>
<li class="chapter" data-level="16.4.5" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#kardiovaskulära-biverkningar"><i class="fa fa-check"></i><b>16.4.5</b> Kardiovaskulära biverkningar</a></li>
</ul></li>
<li class="chapter" data-level="16.5" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#ect-method"><i class="fa fa-check"></i><b>16.5</b> Metod</a>
<ul>
<li class="chapter" data-level="16.5.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#den-elektriska-stimuleringen"><i class="fa fa-check"></i><b>16.5.1</b> Den elektriska stimuleringen</a></li>
<li class="chapter" data-level="16.5.2" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#checklista-för-ect-administration"><i class="fa fa-check"></i><b>16.5.2</b> Checklista för ECT-administration</a></li>
</ul></li>
<li class="chapter" data-level="16.6" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#behandlingsintervall-och-seriens-längd"><i class="fa fa-check"></i><b>16.6</b> Behandlingsintervall och seriens längd</a>
<ul>
<li class="chapter" data-level="16.6.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#indexserien"><i class="fa fa-check"></i><b>16.6.1</b> Indexserien</a></li>
<li class="chapter" data-level="16.6.2" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#antal-behandlingar-per-vecka"><i class="fa fa-check"></i><b>16.6.2</b> Antal behandlingar per vecka</a></li>
<li class="chapter" data-level="16.6.3" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#fortsättnings-ect-och-underhålls-ect"><i class="fa fa-check"></i><b>16.6.3</b> Fortsättnings-ECT och underhålls-ECT</a></li>
</ul></li>
<li class="chapter" data-level="16.7" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#återfallsförebyggande-behandling"><i class="fa fa-check"></i><b>16.7</b> Återfallsförebyggande behandling</a>
<ul>
<li class="chapter" data-level="16.7.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#samtidig-läkemedelsbehandling-1"><i class="fa fa-check"></i><b>16.7.1</b> Samtidig läkemedelsbehandling</a></li>
</ul></li>
<li class="chapter" data-level="16.8" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#uppföljning-och-utvärdering-av-behandlingen"><i class="fa fa-check"></i><b>16.8</b> Uppföljning och utvärdering av behandlingen</a>
<ul>
<li class="chapter" data-level="16.8.1" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#återfallsrisk"><i class="fa fa-check"></i><b>16.8.1</b> Återfallsrisk</a></li>
</ul></li>
<li class="chapter" data-level="16.9" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#information-till-patient-och-anhöriga"><i class="fa fa-check"></i><b>16.9</b> Information till patient och anhöriga</a></li>
<li class="chapter" data-level="16.10" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#resurser-4"><i class="fa fa-check"></i><b>16.10</b> Resurser</a></li>
<li class="chapter" data-level="16.11" data-path="elektrokonvulsiv-terapi.html"><a href="elektrokonvulsiv-terapi.html#definitioner"><i class="fa fa-check"></i><b>16.11</b> Definitioner</a></li>
</ul></li>
<li class="chapter" data-level="17" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html"><i class="fa fa-check"></i><b>17</b> Beteendepsykologi</a>
<ul>
<li class="chapter" data-level="17.1" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#begrepp"><i class="fa fa-check"></i><b>17.1</b> Begrepp</a></li>
<li class="chapter" data-level="17.2" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#respondent-conditioning"><i class="fa fa-check"></i><b>17.2</b> Respondent inlärning</a>
<ul>
<li class="chapter" data-level="17.2.1" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#exempel-på-respondent-inlärning"><i class="fa fa-check"></i><b>17.2.1</b> Exempel på respondent inlärning</a></li>
<li class="chapter" data-level="17.2.2" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#kliniska-exempel-på-respondent-inlärning"><i class="fa fa-check"></i><b>17.2.2</b> Kliniska exempel på respondent inlärning</a></li>
</ul></li>
<li class="chapter" data-level="17.3" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#operant-conditioning"><i class="fa fa-check"></i><b>17.3</b> Operant inlärning</a></li>
<li class="chapter" data-level="17.4" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#fördjupning-och-andra-teorier-om-inlärning"><i class="fa fa-check"></i><b>17.4</b> Fördjupning och andra teorier om inlärning</a></li>
<li class="chapter" data-level="17.5" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#basala-affekter"><i class="fa fa-check"></i><b>17.5</b> Basala affekter</a></li>
<li class="chapter" data-level="17.6" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#behaviour-description"><i class="fa fa-check"></i><b>17.6</b> Kartläggning och beskrivning av beteenden</a>
<ul>
<li class="chapter" data-level="17.6.1" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#topographic-analysis"><i class="fa fa-check"></i><b>17.6.1</b> Topografisk analys</a></li>
<li class="chapter" data-level="17.6.2" data-path="behavioural-psychology.html"><a href="behavioural-psychology.html#funktionell-analys"><i class="fa fa-check"></i><b>17.6.2</b> Funktionell analys</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="18" data-path="cbt.html"><a href="cbt.html"><i class="fa fa-check"></i><b>18</b> Kognitiv betendeterapi</a>
<ul>
<li class="chapter" data-level="18.1" data-path="cbt.html"><a href="cbt.html#behandlingsprinciper-1"><i class="fa fa-check"></i><b>18.1</b> Behandlingsprinciper</a></li>
<li class="chapter" data-level="18.2" data-path="cbt.html"><a href="cbt.html#problemlösning"><i class="fa fa-check"></i><b>18.2</b> Problemlösning</a></li>
<li class="chapter" data-level="18.3" data-path="cbt.html"><a href="cbt.html#beteendekontrakt"><i class="fa fa-check"></i><b>18.3</b> Beteendekontrakt</a></li>
<li class="chapter" data-level="18.4" data-path="cbt.html"><a href="cbt.html#kliniskt-problem-självskada-på-avdelningen"><i class="fa fa-check"></i><b>18.4</b> Kliniskt problem: Självskada på avdelningen</a></li>
<li class="chapter" data-level="18.5" data-path="cbt.html"><a href="cbt.html#social-skills"><i class="fa fa-check"></i><b>18.5</b> Social färdighetsträning</a></li>
<li class="chapter" data-level="18.6" data-path="cbt.html"><a href="cbt.html#exponering"><i class="fa fa-check"></i><b>18.6</b> Exponering</a></li>
<li class="chapter" data-level="18.7" data-path="cbt.html"><a href="cbt.html#beteendeaktivering"><i class="fa fa-check"></i><b>18.7</b> Beteendeaktivering</a></li>
</ul></li>
<li class="chapter" data-level="19" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html"><i class="fa fa-check"></i><b>19</b> Psykiatrisk tvångsvård</a>
<ul>
<li class="chapter" data-level="19.1" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#allvarlig-psykisk-störning-1"><i class="fa fa-check"></i><b>19.1</b> Allvarlig psykisk störning</a></li>
<li class="chapter" data-level="19.2" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#vem-får-göra-vad"><i class="fa fa-check"></i><b>19.2</b> Vem får göra vad?</a></li>
<li class="chapter" data-level="19.3" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#äldrejuridik"><i class="fa fa-check"></i><b>19.3</b> Äldrejuridik</a></li>
<li class="chapter" data-level="19.4" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#lpt-lagtext-med-sammanfattningar-och-kommentarer"><i class="fa fa-check"></i><b>19.4</b> LPT lagtext med sammanfattningar och kommentarer</a>
<ul>
<li class="chapter" data-level="19.4.1" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#inledande-bestämmelser"><i class="fa fa-check"></i><b>19.4.1</b> Inledande bestämmelser</a></li>
<li class="chapter" data-level="19.4.2" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#förutsättningar-för-tvångsvård"><i class="fa fa-check"></i><b>19.4.2</b> Förutsättningar för tvångsvård</a></li>
<li class="chapter" data-level="19.4.3" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#intagning-för-tvångsvård"><i class="fa fa-check"></i><b>19.4.3</b> Intagning för tvångsvård</a></li>
<li class="chapter" data-level="19.4.4" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#intagningsbeslut"><i class="fa fa-check"></i><b>19.4.4</b> Intagningsbeslut</a></li>
<li class="chapter" data-level="19.4.5" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#tvångsvård-efter-beslut-av-rätten"><i class="fa fa-check"></i><b>19.4.5</b> Tvångsvård efter beslut av rätten</a></li>
<li class="chapter" data-level="19.4.6" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#gemensamma-bestämmelser-om-vården"><i class="fa fa-check"></i><b>19.4.6</b> Gemensamma bestämmelser om vården</a></li>
</ul></li>
<li class="chapter" data-level="19.5" data-path="psykiatrisk-tvångsvård.html"><a href="psykiatrisk-tvångsvård.html#resurser-5"><i class="fa fa-check"></i><b>19.5</b> Resurser</a></li>
</ul></li>
<li class="chapter" data-level="20" data-path="intyg.html"><a href="intyg.html"><i class="fa fa-check"></i><b>20</b> Intyg</a>
<ul>
<li class="chapter" data-level="20.1" data-path="intyg.html"><a href="intyg.html#tandvårdsstöd"><i class="fa fa-check"></i><b>20.1</b> Tandvårdsstöd</a></li>
<li class="chapter" data-level="20.2" data-path="intyg.html"><a href="intyg.html#körkort"><i class="fa fa-check"></i><b>20.2</b> Körkort</a>
<ul>
<li class="chapter" data-level="20.2.1" data-path="intyg.html"><a href="intyg.html#riskbedömning-1"><i class="fa fa-check"></i><b>20.2.1</b> Riskbedömning</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="21" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html"><i class="fa fa-check"></i><b>21</b> Anteckningar om vetenskaplig metod</a>
<ul>
<li class="chapter" data-level="21.1" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#inledning-5"><i class="fa fa-check"></i><b>21.1</b> Inledning</a></li>
<li class="chapter" data-level="21.2" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#population"><i class="fa fa-check"></i><b>21.2</b> Population</a></li>
<li class="chapter" data-level="21.3" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#beräkning-av-varians-och-precision"><i class="fa fa-check"></i><b>21.3</b> Beräkning av varians och precision</a>
<ul>
<li class="chapter" data-level="21.3.1" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#effekt"><i class="fa fa-check"></i><b>21.3.1</b> Effekt</a></li>
<li class="chapter" data-level="21.3.2" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#medelvärde-mm"><i class="fa fa-check"></i><b>21.3.2</b> Medelvärde mm</a></li>
</ul></li>
<li class="chapter" data-level="21.4" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#rr-och-or"><i class="fa fa-check"></i><b>21.4</b> RR och OR</a></li>
<li class="chapter" data-level="21.5" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#prediktionsintervall"><i class="fa fa-check"></i><b>21.5</b> Prediktionsintervall</a></li>
<li class="chapter" data-level="21.6" data-path="anteckningar-om-vetenskaplig-metod.html"><a href="anteckningar-om-vetenskaplig-metod.html#resurser-6"><i class="fa fa-check"></i><b>21.6</b> Resurser</a></li>
</ul></li>
<li class="chapter" data-level="22" data-path="epilog.html"><a href="epilog.html"><i class="fa fa-check"></i><b>22</b> Epilog</a></li>
<li class="chapter" data-level="23" data-path="ordlista.html"><a href="ordlista.html"><i class="fa fa-check"></i><b>23</b> Ordlista</a></li>
<li class="chapter" data-level="24" data-path="referenser-2.html"><a href="referenser-2.html"><i class="fa fa-check"></i><b>24</b> Referenser</a></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Psykiatriboken</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="referenser-2" class="section level1 hasAnchor" number="24">
<h1><span class="header-section-number">Kapitel 24</span> Referenser<a href="referenser-2.html#referenser-2" class="anchor-section" aria-label="Anchor link to header"></a></h1>

<div id="refs" class="references csl-bib-body">
<div class="csl-entry">
<div class="csl-left-margin">1. </div><div class="csl-right-inline">Meyer JM. The clozapine handbook. 1st ed. Cambridge university press, Cambridge, UK: 2020 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">2. </div><div class="csl-right-inline">Volkow ND, Morales M. <a href="https://doi.org/10.1016/j.cell.2015.07.046">The brain on drugs: From reward to addiction</a>. Cell 2015; 162: 712–25</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">3. </div><div class="csl-right-inline">Macpherson T, Morita M, Hikida T. <a href="https://doi.org/10.3389/fpsyg.2014.01301">Striatal direct and indirect pathways control decision-making behavior</a>. Front Psychol 2014; 5: 1301</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">4. </div><div class="csl-right-inline">Koob GF, Ahmed SH, Boutrel B, et al. <a href="https://doi.org/10.1016/j.neubiorev.2003.11.007">Neurobiological mechanisms in the transition from drug use to drug dependence</a>. Neurosci Biobehav Rev 2004; 27: 739–49</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">5. </div><div class="csl-right-inline">Boileau I, Assaad JM, Pihl RO, et al. <a href="https://doi.org/10.1002/syn.10226">Alcohol promotes dopamine release in the human nucleus accumbens</a>. Synapse 2003; 49: 226–31</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">6. </div><div class="csl-right-inline">Roberto M, Varodayan FP. <a href="https://doi.org/10.1016/j.neuropharm.2017.01.013">Synaptic targets: Chronic alcohol actions</a>. Neuropharmacology 2017; 122: 85–99</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Monte SM de la, Kril JJ. <a href="https://doi.org/10.1007/s00401-013-1233-3">Human alcohol-related neuropathology</a>. Acta Neuropathol 2014; 127: 71–90</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">8. </div><div class="csl-right-inline">Bohn MJ, Babor TF, Kranzler HR. <a href="https://www.ncbi.nlm.nih.gov/pubmed/7674678">The alcohol use disorders identification test (AUDIT): Validation of a screening instrument for use in medical settings</a>. J Stud Alcohol 1995; 56: 423–32</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">9. </div><div class="csl-right-inline">Reinert DF, Allen JP. <a href="https://doi.org/10.1111/j.1530-0277.2006.00295.x">The alcohol use disorders identification test: An update of research findings</a>. Alcohol Clin Exp Res 2007; 31: 185–99</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">10. </div><div class="csl-right-inline">Läkemedelsindustriföreningens Service AB. <a href="https://www.fass.se">Farmacevtiska specialiteter i sverige <span>(FASS)</span></a>. 2020</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">11. </div><div class="csl-right-inline">The Swedish Council on Technology Assessment in Health Care. <span class="nocase">Riskbed<span class="nocase">ö</span>mningar inom psykiatrin - Kan v<span class="nocase">å</span>ld i samh<span class="nocase">ä</span>llet f<span class="nocase">ö</span>ruts<span class="nocase">ä</span>gas?</span> 2005</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">12. </div><div class="csl-right-inline">Andreasson H, Nyman M, Krona H, et al. <a href="https://doi.org/10.1016/j.ijlp.2014.02.038"><span class="nocase">Predictors of Length of Stay in Forensic Psychiatry: the Influence of Perceived Risk of violence</span></a>. <span>Int J Law Psychiatry</span> 2014; 37: 635–42</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">13. </div><div class="csl-right-inline">Berg JM, Smith SF, Watts AL, Ammirati R, Green SE, Lilienfeld SO. Misconceptions regarding psychopathic personality: Implications for clinical practice and research. Neuropsychiatry 2013; 63–74</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">14. </div><div class="csl-right-inline">Glenn AL, Raine A. <a href="https://doi.org/10.1038/nrn3640"><span class="nocase">Neurocriminology: Implications for the Punishment, Prediction and Prevention of Criminal behaviour</span></a>. <span>Nat Rev Neurosci</span> 2014; 15: 54–63</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">15. </div><div class="csl-right-inline">Sariaslan A, Lichtenstein P, Larsson H, Fazel S. <a href="https://doi.org/10.1001/jamapsychiatry.2016.1349"><span class="nocase">Triggers for Violent Criminality in Patients With Psychotic Disorders</span></a>. <span>JAMA Psychiatry</span> 2016; 73: 796–803</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">16. </div><div class="csl-right-inline">Kennedy SH, Lam RW, McIntyre RS, et al. <a href="https://doi.org/10.1177/0706743716659417">Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3 Pharmacological treatments</a>. Can J Psychiatry 2016; 61: 540–60</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">17. </div><div class="csl-right-inline">Trust HPUNF. <a href="https://hertsvalleysccg.nhs.uk/application/files/1615/3633/3654/Guidelines_on_Choice_and_Selection_of_Antidepressants_for_the_Management_of_Depression_Final_Sept_2016.pdf">Guidelines on choice and selection of antidepressants for the management of depression</a>. 2016</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">18. </div><div class="csl-right-inline">Cowen PJ. <a href="https://doi.org/10.1017/S003329171700068X">Backing into the future: Pharmacological approaches to the management of resistant depression</a>. Psychol Med 2017; 47: 2569–77</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">19. </div><div class="csl-right-inline">Cipriani A, Furukawa TA, Salanti G, et al. <a href="https://doi.org/10.1016/S0140-6736(17)32802-7">Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis</a>. Lancet 2018; 391: 1357–66</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">20. </div><div class="csl-right-inline">American Psychiatric Association. <span class="nocase">Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders</span>. 5th ed. <span>American Psychiatric Association</span>, <span>Arlington, VA</span>: 2013 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">21. </div><div class="csl-right-inline">Perlemuter G, Cacoub P, Valla D, et al. <a href="https://doi.org/10.1007/s40263-016-0351-6">Characterisation of <span>Agomelatine</span>-<span>Induced</span> <span>Increase</span> in <span>Liver</span> <span>Enzymes</span>: <span>Frequency</span> and <span>Risk</span> <span>Factors</span> <span>Determined</span> from a <span>Pooled</span> <span>Analysis</span> of 7605 <span>Treated</span> <span>Patients</span></a>. CNS drugs 2016; 30: 877–88</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">22. </div><div class="csl-right-inline">Khan A, Leventhal RM, Khan SR, Brown WA. <a href="https://doi.org/10.1097/00004714-200202000-00007">Severity of depression and response to antidepressants and placebo: An analysis of the <span>Food</span> and <span>Drug</span> <span>Administration</span> database</a>. Journal of Clinical Psychopharmacology 2002; 22: 40–5</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">23. </div><div class="csl-right-inline">Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. <a href="https://doi.org/10.1371/journal.pmed.0050045">Initial <span>Severity</span> and <span>Antidepressant</span> <span>Benefits</span>: <span>A</span> <span>Meta</span>-<span>Analysis</span> of <span>Data</span> <span>Submitted</span> to the <span>Food</span> and <span>Drug</span> <span>Administration</span></a>. PLOS Medicine 2008; 5: e45</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">24. </div><div class="csl-right-inline">Vöhringer PA, Ghaemi SN. <a href="https://doi.org/10.1016/j.clinthera.2011.11.019">Solving the <span>Antidepressant</span> <span>Efficacy</span> <span>Question</span>? <span>Effect</span> <span>Sizes</span> in <span>Major</span> <span>Depressive</span> <span>Disorder</span></a>. Clinical therapeutics 2011; 33: B49–61</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">25. </div><div class="csl-right-inline">Rabinowitz J, Werbeloff N, Mandel FS, Menard F, Marangell L, Kapur S. <a href="https://doi.org/10.1192/bjp.bp.115.173906">Initial depression severity and response to antidepressants v Placebo: Patient-level data analysis from 34 randomised controlled trials</a>. The British Journal of Psychiatry: The Journal of Mental Science 2016; 209: 427–8</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">26. </div><div class="csl-right-inline">Borges S, Chen Y-F, Laughren TP, et al. <a href="https://doi.org/10.4088/JCP.13r08722">Review of <span>Maintenance</span> <span>Trials</span> for <span>Major</span> <span>Depressive</span> <span>Disorder</span>: <span>A</span> 25-<span>Year</span> <span>Perspective</span> <span>From</span> the <span>US</span> <span>Food</span> and <span>Drug</span> <span>Administration</span></a>. The Journal of Clinical Psychiatry 2014; 75: 18305</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">27. </div><div class="csl-right-inline">Geddes JR, Carney SM, Davies C, et al. <a href="https://doi.org/10.1016/S0140-6736(03)12599-8">Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review</a>. The Lancet 2003; 361: 653–61</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">28. </div><div class="csl-right-inline">Kato M, Hori H, Inoue T, et al. <a href="https://doi.org/10.1038/s41380-020-0843-0">Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: A systematic review and meta-analysis</a>. Molecular Psychiatry 2021; 26: 118–33</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">29. </div><div class="csl-right-inline">Andrews PW, Kornstein SG, Halberstadt LJ, Gardner CO, Neale MC. <a href="https://doi.org/10.3389/fpsyg.2011.00159">Blue <span>Again</span>: <span>Perturbational</span> <span>Effects</span> of <span>Antidepressants</span> <span>Suggest</span> <span>Monoaminergic</span> <span>Homeostasis</span> in <span>Major</span> <span>Depression</span></a>. Frontiers in Psychology 2011; 2: 159</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">30. </div><div class="csl-right-inline">Hengartner MP, Plöderl M. <a href="https://doi.org/10.1177/20451253211032051">Prophylactic effects or withdrawal reactions? <span>An</span> analysis of time-to-event data from antidepressant relapse prevention trials submitted to the <span>FDA</span></a>. Therapeutic Advances in Psychopharmacology 2021; 11: 20451253211032051</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">31. </div><div class="csl-right-inline">Horder J, Matthews P, Waldmann R. <a href="https://doi.org/10.1177/0269881110372544">Placebo, prozac and <span>PLoS</span>: Significant lessons for psychopharmacology</a>. Journal of Psychopharmacology (Oxford, England) 2011; 25: 1277–88</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">32. </div><div class="csl-right-inline">Kirsch I, Moncrieff J. <a href="https://doi.org/10.1016/j.cct.2006.10.012">Clinical trials and the response rate illusion</a>. Contemporary Clinical Trials 2007; 28: 348–51</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">33. </div><div class="csl-right-inline">Ruhé HG, Huyser J, Swinkels JA, Schene AH. <a href="https://doi.org/10.4088/jcp.v67n1203"><span class="nocase">Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review</span></a>. <span>J Clin Psychiatry</span> 2006; 67: 1836–55</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">34. </div><div class="csl-right-inline">Taylor D, Barnes T, Young A. The maudsley prescribing guidelines in psychiatry. 13th ed. Wiley-Blackwell, Hoboken, NJ: 2018 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">35. </div><div class="csl-right-inline">Gaynes BN. <a href="https://doi.org/10.4088/JCP.8133su1c.02"><span class="nocase">Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities</span></a>. <span>J Clin Psychiatry</span> 2009; 70 Suppl 6: 10–5</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">36. </div><div class="csl-right-inline">Taylor RW, Marwood L, Oprea E, et al. <a href="https://doi.org/10.1093/ijnp/pyaa033"><span class="nocase">Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines</span></a>. <span>Int J Neuropsychopharmacol</span> 2020; 23: 587–625</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">37. </div><div class="csl-right-inline">Lam RW, Kennedy SH, Adams C, et al. <a href="https://doi.org/10.1177/07067437241245384">Canadian <span>Network</span> for <span>Mood</span> and <span>Anxiety</span> <span>Treatments</span> (<span>CANMAT</span>) 2023 <span>Update</span> on <span>Clinical</span> <span>Guidelines</span> for <span>Management</span> of <span>Major</span> <span>Depressive</span> <span>Disorder</span> in <span>Adults</span>: <span>Réseau</span> canadien pour les traitements de l’humeur et de l’anxiété (<span>CANMAT</span>) 2023 : <span>Mise</span> à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes</a>. Canadian Journal of Psychiatry Revue Canadienne De Psychiatrie 2024; 7067437241245384</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">38. </div><div class="csl-right-inline">Lopes Rocha F, Fuzikawa C, Riera R, Ramos MG, Hara C. <a href="https://doi.org/10.1016/j.jad.2012.04.048"><span class="nocase">Antidepressant combination for major depression in incomplete responders–a systematic review</span></a>. <span>J Affect Disord</span> 2013; 144: 1–6</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">39. </div><div class="csl-right-inline">Henssler J, Bschor T, Baethge C. <a href="https://doi.org/10.1177/0706743715620411"><span class="nocase">Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients</span></a>. <span>Can J Psychiatry</span> 2016; 61: 29–43</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">40. </div><div class="csl-right-inline">Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. <a href="https://doi.org/10.1016/S2215-0366(19)30217-2"><span class="nocase">Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis</span></a>. <span>Lancet Psychiatry</span> 2019; 6: 601–9</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">41. </div><div class="csl-right-inline">Hieronymus F. <a href="https://doi.org/10.1016/S2215-0366(19)30221-4"><span class="nocase">Which antidepressant doses are optimal?</span></a> <span>Lancet Psychiatry</span> 2019; 6: 552–4</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">42. </div><div class="csl-right-inline">Dold M, Bartova L, Rupprecht R, Kasper S. <a href="https://doi.org/10.1159/000477770"><span class="nocase">Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials</span></a>. <span>Psychother Psychosom</span> 2017; 86: 283–91</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">43. </div><div class="csl-right-inline">Hieronymus F, Lisinski A, Nilsson S, Eriksson E. <a href="https://doi.org/10.1038/mp.2017.147">Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: A mega-analysis of citalopram and paroxetine in adult depression</a>. Mol Psychiatry 2018; 23: 1731–6</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">44. </div><div class="csl-right-inline">Sinyor M, Cheung CP, Abraha HY, et al. <a href="https://doi.org/10.1016/j.jad.2020.02.013">Antidepressant-placebo differences for specific adverse events in major depressive disorder: <span>A</span> systematic review</a>. Journal of Affective Disorders 2020; 267: 185–90</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">45. </div><div class="csl-right-inline">Dent R, Blackmore A, Peterson J, et al. <a href="https://doi.org/10.1371/journal.pone.0036889">Changes in <span>Body</span> <span>Weight</span> and <span>Psychotropic</span> <span>Drugs</span>: <span>A</span> <span>Systematic</span> <span>Synthesis</span> of the <span>Literature</span></a>. PLOS ONE 2012; 7: e36889</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">46. </div><div class="csl-right-inline">Salvi V, Mencacci C, Barone-Adesi F. <a href="https://doi.org/10.1016/j.euroneuro.2016.08.012">H1-histamine receptor affinity predicts weight gain with antidepressants</a>. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2016; 26: 1673–7</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">47. </div><div class="csl-right-inline">Baldwin DS, Montgomery SA, Nil R, Lader M. <a href="https://doi.org/10.1017/S1461145705006358">Discontinuation symptoms in depression and anxiety disorders</a>. The International Journal of Neuropsychopharmacology 2007; 10: 73–84</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">48. </div><div class="csl-right-inline">Räisänen S, Lehto SM, Nielsen HS, Gissler M, Kramer MR, Heinonen S. <a href="https://doi.org/10.1136/bmjopen-2014-004883">Risk factors for and perinatal outcomes of major depression during pregnancy: A population-based analysis during 2002-2010 in finland</a>. BMJ Open 2014; 4: e004883</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">49. </div><div class="csl-right-inline">Langan R, Goodbred AJ. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27175720">Identification and management of peripartum depression</a>. Am Fam Physician 2016; 93: 852–8</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">50. </div><div class="csl-right-inline">Stone MB, Yaseen ZS, Miller BJ, Richardville K, Kalaria SN, Kirsch I. <a href="https://doi.org/10.1136/bmj-2021-067606">Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the <span>US</span> <span>Food</span> and <span>Drug</span> <span>Administration</span>: Individual participant data analysis</a>. BMJ 2022; 378: e067606</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">51. </div><div class="csl-right-inline">Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI. <a href="https://doi.org/10.4088/JCP.10r06531"><span class="nocase">Efficacy of Antidepressants for Late-Life Depression: a Meta-Analysis and Meta-Regression of Placebo-Controlled Randomized trials</span></a>. <span>J Clin Psychiatry</span> 2011; 72: 1660–8</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">52. </div><div class="csl-right-inline">Bartels SJ, Dums AR, Oxman TE, et al. <a href="https://doi.org/10.1016/s0193-953x(03)00072-8"><span class="nocase">Evidence-Based Practices in Geriatric Mental Health Care: an Overview of Systematic Reviews and meta-Analyses</span></a>. <span>Psychiatr Clin North Am</span> 2003; 26: 971–90, x–xi</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">53. </div><div class="csl-right-inline">Lenze Eric J., Mulsant Benoit H., Roose Steven P., et al. <a href="https://doi.org/10.1056/NEJMoa2204462">Antidepressant <span>Augmentation</span> versus <span>Switch</span> in <span>Treatment</span>-<span>Resistant</span> <span>Geriatric</span> <span>Depression</span></a>. New England Journal of Medicine 2023; 388: 1067–79</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">54. </div><div class="csl-right-inline">Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. <a href="https://doi.org/10.1056/NEJMsa065779">Selective publication of antidepressant trials and its influence on apparent efficacy</a>. The New England Journal of Medicine 2008; 358: 252–60</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">55. </div><div class="csl-right-inline">Ioannidis JP. <a href="https://doi.org/10.1186/1747-5341-3-14">Effectiveness of antidepressants: An evidence myth constructed from a thousand randomized trials?</a> Philosophy, Ethics, and Humanities in Medicine 2008; 3: 14</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">56. </div><div class="csl-right-inline">Goodwin FK, Jamison KR. <span class="nocase">Manic-depressive illness: bipolar disorders and recurrent depression</span>. Oxford University Press: 2007 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">57. </div><div class="csl-right-inline">Vieta E, Berk M, Schulze TG, et al. <a href="https://doi.org/10.1038/nrdp.2018.8">Bipolar disorders</a>. <span>Nat Rev Dis Primers</span> 2018; 4: 18008</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">58. </div><div class="csl-right-inline">Yatham LN, Kennedy SH, Parikh SV, et al. <a href="https://doi.org/10.1111/bdi.12609"><span class="nocase">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder</span></a>. <span>Bipolar Disord</span> 2018; 20: 97–170</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">59. </div><div class="csl-right-inline">Cassidy F, Murry E, Forest K, Carroll BJ. <a href="https://www.ncbi.nlm.nih.gov/pubmed/9858078">Signs and symptoms of mania in pure and mixed episodes</a>. J Affect Disord 1998; 50: 187–201</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">60. </div><div class="csl-right-inline">Vöhringer PA, Perlis RH. <a href="https://doi.org/10.1016/j.psc.2015.10.001">Discriminating <span>Between</span> <span>Bipolar</span> <span>Disorder</span> and <span>Major</span> <span>Depressive</span> <span>Disorder</span></a>. The Psychiatric Clinics of North America 2016; 39: 1–10</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">61. </div><div class="csl-right-inline">Benazzi F, Akiskal H. <a href="https://doi.org/10.1016/j.jad.2004.07.006"><span class="nocase">Irritable-hostile depression: further validation as a bipolar depressive mixed state</span></a>. <span>J Affect Disord</span> 2005; 84: 197–207</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">62. </div><div class="csl-right-inline">Lu Z, Wang Y, Xun G. <a href="https://doi.org/10.1038/s41598-021-97955-4">Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: A case–control study</a>. Scientific Reports 2021; 11: 18307</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">63. </div><div class="csl-right-inline">Engmann B. <a href="https://doi.org/10.1155/2012/389851"><span class="nocase">Bipolar affective disorder and migraine</span></a>. <span>Case Rep Med</span> 2012; 2012: 389851</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">64. </div><div class="csl-right-inline">Larson EW, Richelson E. <a href="https://doi.org/10.1016/s0025-6196(12)62694-9"><span class="nocase">Organic Causes of mania</span></a>. <span>Mayo Clin Proc</span> 1988; 63: 906–12</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">65. </div><div class="csl-right-inline">Jeong J-H, Bahk W-M, Woo YS, et al. <a href="https://doi.org/10.9758/cpn.2023.21.1.32">Korean <span>Medication</span> <span>Algorithm</span> <span>Project</span> for <span>Bipolar</span> <span>Disorder</span> 2022: <span>Comparisons</span> with <span>Other</span> <span>Treatment</span> <span>Guidelines</span></a>. Clinical Psychopharmacology and Neuroscience 2023; 21: 32–48</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">66. </div><div class="csl-right-inline">Keramatian K, Chithra NK, Yatham LN. <a href="https://doi.org/10.1176/appi.focus.20230009">The <span>CANMAT</span> and <span>ISBD</span> <span>Guidelines</span> for the <span>Treatment</span> of <span>Bipolar</span> <span>Disorder</span>: <span>Summary</span> and a 2023 <span>Update</span> of <span>Evidence</span></a>. Focus 2023; 21: 344–53</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">67. </div><div class="csl-right-inline">Abé C, Ekman CJ, Sellgren C, Petrovic P, Ingvar M, Landén M. <a href="https://doi.org/10.1093/brain/awv266">Manic episodes are related to changes in frontal cortex: <span>A</span> longitudinal neuroimaging study of bipolar disorder 1</a>. Brain 2015; 138: 3440–8</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">68. </div><div class="csl-right-inline">Baldessarini RJ, Vázquez GH, Tondo L. <a href="https://doi.org/10.1186/s40345-019-0160-1">Bipolar depression: A major unsolved challenge</a>. International Journal of Bipolar Disorders 2020; 8: 1</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">69. </div><div class="csl-right-inline">Nolen WA, Licht RW, Young AH, et al. <a href="https://doi.org/10.1111/bdi.12805"><span class="nocase">What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium</span></a>. <span>Bipolar Disord</span> 2019; 21: 394–409</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">70. </div><div class="csl-right-inline">Severus WE, Kleindienst N, Seemüller F, Frangou S, Möller HJ, Greil W. <a href="https://doi.org/10.1111/j.1399-5618.2007.00475.x"><span class="nocase">What is the optimal serum lithium level in the long-term treatment of bipolar disorder–a review?</span></a> <span>Bipolar Disord</span> 2008; 10: 231–7</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">71. </div><div class="csl-right-inline">Carter L, Zolezzi M, Lewczyk A. <a href="https://doi.org/10.1177/070674371305801009"><span class="nocase">An updated review of the optimal lithium dosage regimen for renal protection</span></a>. <span>Can J Psychiatry</span> 2013; 58: 595–600</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">72. </div><div class="csl-right-inline">Bowen RC, Grof P, Grof E. <a href="https://doi.org/10.1176/ajp.148.2.189"><span class="nocase">Less frequent lithium administration and lower urine volume</span></a>. <span>Am J Psychiatry</span> 1991; 148: 189–92</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">73. </div><div class="csl-right-inline">Lorberg B, Youssef NA, Bhagwagar Z. <a href="https://doi.org/10.1017/S1461145708009504"><span class="nocase">Lamotrigine-associated rash: to rechallenge or not to rechallenge?</span></a> <span>Int J Neuropsychopharmacol</span> 2009; 12: 257–65</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">74. </div><div class="csl-right-inline">Lee K, Oh H, Lee EH, Kim JH, Kim JH, Hong KS. <a href="https://doi.org/10.1186/s12888-016-0831-8">Investigation of the clinical utility of the hypomania checklist 32 (HCL-32) for the screening of bipolar disorders in the non-clinical adult population</a>. BMC Psychiatry 2016; 16: 124</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">75. </div><div class="csl-right-inline">Vieta E, Valentí M. <a href="https://doi.org/10.1016/j.jad.2013.03.007">Mixed states in DSM-5: Implications for clinical care, education, and research</a>. J Affect Disord 2013; 148: 28–36</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">76. </div><div class="csl-right-inline">Yatham LN, Kennedy SH, Parikh SV, et al. <a href="https://doi.org/10.1111/bdi.12025">Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013</a>. Bipolar Disord 2013; 15: 1–44</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">77. </div><div class="csl-right-inline">Svenska Psykiatriska Föreningen. Bipolär sjukdom - kliniska riktlinjer för utredning och behandling. 1st ed. Gothia Fortbildning AB, Stockholm: 2014 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">78. </div><div class="csl-right-inline">Severus E, Bauer M, Geddes J. <a href="https://doi.org/10.1055/a-0627-7489">Efficacy and effectiveness of lithium in the long-term treatment of bipolar disorders: An update 2018</a>. Pharmacopsychiatry Published Online First: June 2018</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">79. </div><div class="csl-right-inline">Yoshida K, Uchida H, Suzuki T, et al. <a href="https://doi.org/10.1055/s-0043-116855">Prediction model of serum lithium concentrations</a>. Pharmacopsychiatry 2018; 51: 82–8</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">80. </div><div class="csl-right-inline">Selle V, Schalkwijk S, Vázquez GH, Baldessarini RJ. <a href="https://doi.org/10.1055/s-0033-1363258">Treatments for acute bipolar depression: Meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics</a>. Pharmacopsychiatry 2014; 47: 43–52</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">81. </div><div class="csl-right-inline">Garakani A, Murrough JW, Freire RC, et al. <a href="https://doi.org/10.3389/fpsyt.2020.595584"><span class="nocase">Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options</span></a>. <span>Front Psychiatry</span> 2020; 11: 595584</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">82. </div><div class="csl-right-inline">Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR. <a href="https://doi.org/10.1007/s11920-015-0591-z"><span class="nocase">Assessment and Treatment of Anxiety Disorders in Children and adolescents</span></a>. <span>Curr Psychiatry Rep</span> 2015; 17: 52</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">83. </div><div class="csl-right-inline">Kolar D, Keller A, Golfinopoulos M, Cumyn L, Syer C, Hechtman L. <a href="https://doi.org/10.2147/ndt.s1747"><span class="nocase">Treatment of adults with attention-deficit/hyperactivity disorder</span></a>. <span>Neuropsychiatr Dis Treat</span> 2008; 4: 107–21</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">84. </div><div class="csl-right-inline">Gillberg C. <a href="https://doi.org/10.1016/j.ridd.2010.06.002"><span class="nocase">The Essence in Child Psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations</span></a>. <span>Res Dev Disabil</span> 2010; 31: 1543–51</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">85. </div><div class="csl-right-inline">Kryger M, Roth T, Dement WC, editors. <a href="https://doi.org/10.1016/C2012-0-03543-0">Principles and practice of sleep medicine</a>. 6th ed. Elsevier: 2017 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">86. </div><div class="csl-right-inline">Lanciego JL, Luquin N, Obeso JA. <a href="https://doi.org/10.1101/cshperspect.a009621">Functional neuroanatomy of the basal ganglia</a>. Cold Spring Harb Perspect Med 2012; 2: a009621</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">87. </div><div class="csl-right-inline">Esler M. <a href="https://doi.org/10.1113/expphysiol.2010.052332">The sympathetic nervous system through the ages: From thomas willis to resistant hypertension</a>. Exp Physiol 2011; 96: 611–22</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">88. </div><div class="csl-right-inline">Clasadonte J, Prevot V. <a href="https://doi.org/10.1038/nrendo.2017.124">The special relationship: Glia-neuron interactions in the neuroendocrine hypothalamus</a>. Nat Rev Endocrinol 2018; 14: 25–44</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">89. </div><div class="csl-right-inline">Egapp. <a href="https://doi.org/10.1097/gim.0b013e31815bf9a3"><span class="nocase">Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors</span></a>. <span>Genet Med</span> 2007; 9: 819–25</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">90. </div><div class="csl-right-inline">Hiemke C, Bergemann N, Clement HW, et al. <a href="https://doi.org/10.1055/s-0037-1600991">Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017</a>. Pharmacopsychiatry 2018; 51: e1</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">91. </div><div class="csl-right-inline">Hiemke C. <a href="https://doi.org/10.1097/FTD.0000000000000582"><span class="nocase">Concentration-Effect Relationships of Psychoactive Drugs and the Problem to Calculate Therapeutic Reference Ranges</span></a>. <span>Ther Drug Monit</span> 2019; 41: 174–9</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">92. </div><div class="csl-right-inline">Risch SC, Kalin NH, Janowsky DS, Huey LY. <a href="https://doi.org/10.1097/00004714-198103000-00003"><span class="nocase">Indications and guidelines for plasma tricyclic antidepressant concentration monitoring</span></a>. <span>J Clin Psychopharmacol</span> 1981; 1: 59–63</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">93. </div><div class="csl-right-inline">Bengtsson F. <a href="https://doi.org/10.1097/00007691-200404000-00010"><span class="nocase">Therapeutic drug monitoring of psychotropic drugs TDM "nouveau"</span></a>. <span>Ther Drug Monit</span> 2004; 26: 145–51</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">94. </div><div class="csl-right-inline">Schoretsanitis G, Kane JM, Correll CU, et al. <a href="https://doi.org/10.4088/JCP.19cs13169"><span class="nocase">Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie</span></a>. <span>J Clin Psychiatry</span> 2020; 81:</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">95. </div><div class="csl-right-inline">Jukic MM, Smith RL, Haslemo T, Molden E, Ingelman-Sundberg M. <a href="https://doi.org/10.1016/S2215-0366(19)30088-4">Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: A retrospective, cohort study</a>. Lancet Psychiatry Published Online First: April 2019</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">96. </div><div class="csl-right-inline">Sujan AC, Rickert ME, Öberg AS, et al. <a href="https://doi.org/10.1001/jama.2017.3413">Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring</a>. JAMA 2017; 317: 1553–62</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">97. </div><div class="csl-right-inline">Hübner-Liebermann B, Hausner H, Wittmann M. <a href="https://doi.org/10.3238/arztebl.2012.0419">Recognizing and treating peripartum depression</a>. Dtsch Arztebl Int 2012; 109: 419–24</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">98. </div><div class="csl-right-inline">Bayrampour H, Kapoor A, Bunka M, Ryan D. <a href="https://doi.org/10.4088/JCP.19r13134">The <span>Risk</span> of <span>Relapse</span> of <span>Depression</span> <span>During</span> <span>Pregnancy</span> <span>After</span> <span>Discontinuation</span> of <span>Antidepressants</span>: <span>A</span> <span>Systematic</span> <span>Review</span> and <span>Meta</span>-<span>Analysis</span></a>. The Journal of Clinical Psychiatry 2020; 81: 19r13134</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">99. </div><div class="csl-right-inline">Jimenez-Solem E, Andersen JT, Petersen M, et al. <a href="https://doi.org/10.1136/bmjopen-2012-001148">Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: A nationwide cohort study</a>. BMJ open 2012; 2: e001148</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">100. </div><div class="csl-right-inline">Brown JVE, Wilson CA, Ayre K, et al. <a href="https://doi.org/10.1002/14651858.CD013560.pub2">Antidepressant treatment for postnatal depression</a>. Cochrane Database of Systematic Reviews Published Online First: 2021</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">101. </div><div class="csl-right-inline">Gadot Y, Koren G. <a href="https://doi.org/10.1016/S1701-2163(15)30364-9">The use of antidepressants in pregnancy: Focus on maternal risks</a>. Journal of obstetrics and gynaecology Canada: JOGC = Journal d’obstetrique et gynecologie du Canada: JOGC 2015; 37: 56–63</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">102. </div><div class="csl-right-inline">Berney P. <span class="nocase">Dose-response relationship of recent antidepressants in the short-term treatment of depression</span>. <span>Dialogues Clin Neurosci</span> 2005; 7: 249–62</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">103. </div><div class="csl-right-inline">Bech P, Kajdasz DK, Porsdal V. <a href="https://doi.org/10.1007/s00213-006-0505-1"><span class="nocase">Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder</span></a>. <span>Psychopharmacology (Berl)</span> 2006; 188: 273–80</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">104. </div><div class="csl-right-inline">Christensen MC, McIntyre RS, Florea I, Loft H, Fagiolini A. <a href="https://doi.org/10.1017/S1092852921000936"><span class="nocase">Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment</span></a>. <span>CNS Spectr</span> 2021; 1–26</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">105. </div><div class="csl-right-inline">Calvi A, Fischetti I, Verzicco I, et al. <a href="https://doi.org/10.3389/fcvm.2021.704281"><span class="nocase">Antidepressant Drugs Effects on Blood Pressure</span></a>. <span>Front Cardiovasc Med</span> 2021; 8: 704281</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">106. </div><div class="csl-right-inline">Farde L, Wiesel FA, Halldin C, Sedvall G. <a href="https://doi.org/10.1001/archpsyc.1988.01800250087012"><span class="nocase">Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs</span></a>. <span>Arch Gen Psychiatry</span> 1988; 45: 71–6</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">107. </div><div class="csl-right-inline">Solmi M, Pigato G, Kane JM, Correll CU. <a href="https://doi.org/10.1016/j.jns.2018.02.012">Clinical risk factors for the development of tardive dyskinesia</a>. Journal of the Neurological Sciences 2018; 389: 21–7</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">108. </div><div class="csl-right-inline">Stoklosa J, Öngür D. <a href="https://doi.org/10.3109/10673229.2011.614100">Rational antipsychotic choice: Weighing the risk of tardive dyskinesia and metabolic syndrome</a>. Harv Rev Psychiatry 2011; 19: 271–6</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">109. </div><div class="csl-right-inline">Carbon M, Kane JM, Leucht S, Correll CU. <a href="https://doi.org/10.1002/wps.20579">Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: A meta-analysis</a>. World psychiatry: official journal of the World Psychiatric Association (WPA) 2018; 17: 330–40</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">110. </div><div class="csl-right-inline">Pillinger T, McCutcheon RA, Vano L, et al. <a href="https://doi.org/10.1016/S2215-0366(19)30416-X">Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: A systematic review and network meta-analysis</a>. The Lancet Psychiatry 2020; 7: 64–77</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">111. </div><div class="csl-right-inline">Agarwal SM, Stogios N, Ahsan ZA, et al. <a href="https://doi.org/10.1002/14651858.CD013337.pub2">Pharmacological interventions for prevention of weight gain in people with schizophrenia</a>. Cochrane Database of Systematic Reviews Published Online First: 2022</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">112. </div><div class="csl-right-inline">McIntyre RS, Kwan ATH, Rosenblat JD, Teopiz KM, Mansur RB. <a href="https://doi.org/10.1176/appi.ajp.20230922">Psychotropic <span>Drug</span>-<span>Related</span> <span>Weight</span> <span>Gain</span> and <span>Its</span> <span>Treatment</span></a>. The American Journal of Psychiatry 2024; 181: 26–38</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">113. </div><div class="csl-right-inline">Hall RL, Smith AG, Edwards JG. <a href="https://doi.org/10.1517/14740338.2.4.395">Haematological safety of antipsychotic drugs</a>. Expert Opinion on Drug Safety 2003; 2: 395–9</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">114. </div><div class="csl-right-inline">Lieberman JA, Stroup TS, McEvoy JP, et al. <a href="https://doi.org/10.1056/NEJMoa051688">Effectiveness of antipsychotic drugs in patients with chronic schizophrenia</a>. N Engl J Med 2005; 353: 1209–23</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">115. </div><div class="csl-right-inline">Jones PB, Barnes TR, Davies L, et al. <a href="https://doi.org/10.1001/archpsyc.63.10.1079">Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)</a>. Arch Gen Psychiatry 2006; 63: 1079–87</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">116. </div><div class="csl-right-inline">Naber D, Lambert M. <a href="https://doi.org/10.2165/00023210-200923080-00002">The CATIE and CUtLASS studies in schizophrenia: Results and implications for clinicians</a>. CNS Drugs 2009; 23: 649–59</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">117. </div><div class="csl-right-inline">Stern TA, Freudenreich O, Smith FA, Fricchione GL, Rosenbaum JF. <span class="nocase">Massachusetts General Hospital Handbook of General Hospital Psychiatry</span>. 7th ed. Elsevier, Philadelphia, United States: 2017 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">118. </div><div class="csl-right-inline">Shaheen AA, Kaplan GG, Sharkey KA, Lethebe BC, Swain MG. <a href="https://doi.org/10.1111/liv.14973"><span class="nocase">Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study</span></a>. <span>Liver Int</span> 2021; 41: 2308–17</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">119. </div><div class="csl-right-inline">Voican CS, Corruble E, Naveau S, Perlemuter G. <a href="https://doi.org/10.1176/appi.ajp.2013.13050709"><span class="nocase">Antidepressant-Induced Liver Injury: a Review for clinicians</span></a>. <span>Am J Psychiatry</span> 2014; 171: 404–15</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">120. </div><div class="csl-right-inline">Todorović Vukotić N, Đorđević J, Pejić S, Đorđević N, Pajović SB. <a href="https://doi.org/10.1007/s00204-020-02963-4">Antidepressants- and antipsychotics-induced hepatotoxicity</a>. Archives of Toxicology 2021; 95: 767–89</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">121. </div><div class="csl-right-inline">Ulrichsen A, Hampsey E, Taylor RH, Gadelrab R, Strawbridge R, Young AH. <a href="https://doi.org/10.1192/bjo.2023.64">Comparing measurements of lithium treatment efficacy in people with bipolar disorder: Systematic review and meta-analysis</a>. BJPsych Open 2023; 9: e98</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">122. </div><div class="csl-right-inline">TRAUTNER EM, MORRIS R, NOACK CH, GERSHON S. <span class="nocase">The Excretion and Retention of Ingested Lithium and Its Effect on the Ionic Balance of man</span>. <span>Med J Aust</span> 1955; 42: 280–91</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">123. </div><div class="csl-right-inline">Bauer M, Grof P, Muller-Oerlinghausen B. Lithium in neuropsychiatry. The comprehensive guide. 1st ed. Taylor &amp; Francis, Boca Raton, FL: 2013 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">124. </div><div class="csl-right-inline">de Leon, Jose. Pharmacokinetics of lithium. 2016</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">125. </div><div class="csl-right-inline">Grünfeld JP, Rossier BC. <a href="https://doi.org/10.1038/nrneph.2009.43"><span class="nocase">Lithium Nephrotoxicity revisited</span></a>. <span>Nat Rev Nephrol</span> 2009; 5: 270–6</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">126. </div><div class="csl-right-inline">Johnson G. <a href="https://doi.org/10.1016/S0893-133X(98)00019-0"><span class="nocase">Lithium–early development, toxicity, and renal function</span></a>. <span>Neuropsychopharmacology</span> 1998; 19: 200–5</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">127. </div><div class="csl-right-inline">Grandjean EM, Aubry JM. <a href="https://doi.org/10.2165/00023210-200923040-00005"><span class="nocase">Lithium: Updated Human Knowledge Using an Evidence-Based Approach Part Ii: Clinical Pharmacology and Therapeutic monitoring</span></a>. <span>CNS Drugs</span> 2009; 23: 331–49</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">128. </div><div class="csl-right-inline">Kar N, Barreto S, Chandavarkar R. <a href="https://doi.org/10.9758/cpn.2016.14.4.323"><span class="nocase">Clozapine Monitoring in Clinical Practice: Beyond the Mandatory Requirement</span></a>. <span>Clin Psychopharmacol Neurosci</span> 2016; 14: 323–9</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">129. </div><div class="csl-right-inline">Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. 5th ed. American psychiatric association publishing: 2017 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">130. </div><div class="csl-right-inline">Mendelson WB, Roth T, Cassella J, et al. <a href="https://doi.org/10.1016/S1087-0792(03)00042-X"><span class="nocase">The treatment of chronic insomnia: drug indications, chronic use and abuse liability Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium</span></a>. <span>Sleep Med Rev</span> 2004; 8: 7–17</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">131. </div><div class="csl-right-inline">Sanacora G, Frye MA, McDonald W, et al. <a href="https://doi.org/10.1001/jamapsychiatry.2017.0080"><span class="nocase">A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders</span></a>. <span>JAMA Psychiatry</span> 2017; 74: 399–405</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">132. </div><div class="csl-right-inline">Statens Beredning för medicinsk och social utvärdering S. Ketamin vid sv<span>å</span>rbehandlad depression. 2017</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">133. </div><div class="csl-right-inline">Nassir Ghaemi S, Shirzadi AA, Filkowski M. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580079">Publication <span>Bias</span> and the <span>Pharmaceutical</span> <span>Industry</span>: <span>The</span> <span>Case</span> of <span>Lamotrigine</span> in <span>Bipolar</span> <span>Disorder</span></a>. The Medscape Journal of Medicine 2008; 10: 211</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">134. </div><div class="csl-right-inline">Calabrese JR, Huffman RF, White RL, et al. <a href="https://doi.org/10.1111/j.1399-5618.2007.00500.x">Lamotrigine in the acute treatment of bipolar depression: Results of five double-blind, placebo-controlled clinical trials</a>. Bipolar Disorders 2008; 10: 323–33</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">135. </div><div class="csl-right-inline">Geddes JR, Calabrese JR, Goodwin GM. <a href="https://doi.org/10.1192/bjp.bp.107.048504">Lamotrigine for treatment of bipolar depression: Independent meta-analysis and meta-regression of individual patient data from five randomised trials</a>. The British Journal of Psychiatry: The Journal of Mental Science 2009; 194: 4–9</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">136. </div><div class="csl-right-inline">Haenen N, Kamperman AM, Prodan A, Nolen WA, Boks MP, Wesseloo R. <a href="https://doi.org/10.1111/bdi.13452">The efficacy of lamotrigine in bipolar disorder: <span>A</span> systematic review and meta-analysis</a>. Bipolar Disorders 2024; n/a:</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">137. </div><div class="csl-right-inline">Calabrese JR, Bowden CL, Sachs G, et al. <a href="https://doi.org/10.4088/jcp.v64n0906"><span class="nocase">A Placebo-Controlled 18-month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depressed Patients With Bipolar I disorder</span></a>. <span>J Clin Psychiatry</span> 2003; 64: 1013–24</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">138. </div><div class="csl-right-inline">Bowden CL, Calabrese JR, Sachs G, et al. <a href="https://doi.org/10.1001/archpsyc.60.4.392">A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar <span>I</span> disorder</a>. Archives of General Psychiatry 2003; 60: 392–400</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">139. </div><div class="csl-right-inline">Goodwin GM, Bowden CL, Calabrese JR, et al. <a href="https://doi.org/10.4088/jcp.v65n0321">A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar <span>I</span> disorder</a>. The Journal of Clinical Psychiatry 2004; 65: 432–41</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">140. </div><div class="csl-right-inline">Barbee JG, Thompson TR, Jamhour NJ, et al. <a href="https://doi.org/10.4088/JCP.09m05355gre">A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression</a>. The Journal of Clinical Psychiatry 2011; 72: 1405–12</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">141. </div><div class="csl-right-inline">Santos MA, Rocha FL, Hara C. <a href="https://doi.org/10.4088/pcc.v10n0302">Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: A randomized, placebo-controlled, double-blind study</a>. Primary Care Companion to the Journal of Clinical Psychiatry 2008; 10: 187–90</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">142. </div><div class="csl-right-inline">Barbosa L, Berk M, Vorster M. <a href="https://doi.org/10.4088/jcp.v64n0407">A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes</a>. The Journal of Clinical Psychiatry 2003; 64: 403–7</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">143. </div><div class="csl-right-inline">Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J. <a href="https://doi.org/10.4088/jcp.v63n0411">Lamotrigine as adjunct to paroxetine in acute depression: A placebo-controlled, double-blind study</a>. The Journal of Clinical Psychiatry 2002; 63: 337–44</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">144. </div><div class="csl-right-inline">Reid JG, Gitlin MJ, Altshuler LL. <a href="https://doi.org/10.4088/JCP.12r08046">Lamotrigine in psychiatric disorders</a>. The Journal of Clinical Psychiatry 2013; 74: 675–84</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">145. </div><div class="csl-right-inline">Goldberg JF. <a href="https://doi.org/10.4088/JCP.23ac15219">Where <span>Does</span> <span>Lamotrigine</span> <span>Fit</span> in the <span>Pharmacotherapy</span> of <span>Mood</span> <span>Disorders</span>? <span>An</span> <span>Evidence</span>-<span>Based</span> <span>Appraisal</span></a>. The Journal of Clinical Psychiatry 2024; 85: 51396</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">146. </div><div class="csl-right-inline">Besag FMC, Vasey MJ, Sharma AN, Lam ICH. <a href="https://doi.org/10.1177/20451253211045870">Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: A systematic review</a>. Therapeutic Advances in Psychopharmacology 2021; 11: 20451253211045870</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">147. </div><div class="csl-right-inline">Crawford MJ, Sanatinia R, Barrett B, et al. <a href="https://doi.org/10.3310/hta22170">Lamotrigine for people with borderline personality disorder: A <span>RCT</span></a>. Health Technology Assessment (Winchester, England) 2018; 22: 1–68</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">148. </div><div class="csl-right-inline">Wang X, Xiong J, Xu W-H, et al. <a href="https://doi.org/10.1016/j.seizure.2014.12.001">Risk of a lamotrigine-related skin rash: Current meta-analysis and postmarketing cohort analysis</a>. Seizure 2015; 25: 52–61</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">149. </div><div class="csl-right-inline">Hirsch LJ, Weintraub DB, Buchsbaum R, et al. <a href="https://doi.org/10.1111/j.1528-1167.2006.00423.x">Predictors of <span>Lamotrigine</span>-associated <span>Rash</span></a>. Epilepsia 2006; 47: 318–22</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">150. </div><div class="csl-right-inline">Socialstyrelsen. <span class="nocase">L<span class="nocase">ä</span>kemedel som kan orsaka allvarliga rubbningar i hj<span class="nocase">ä</span>rtats rytm Fokus p<span class="nocase">å</span> f<span class="nocase">ö</span>rskrivning av antidepressiva och antipsykotiska l<span class="nocase">ä</span>kemedel till <span class="nocase">ä</span>ldre socialstyrelsen</span>. 2019</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">151. </div><div class="csl-right-inline">Riedel WJ, van Praag HM. Avoiding and managing anticholinergic effects of antidepressants. PRACTICAL THERAPEUTICS 1995; 4: 245–59</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">152. </div><div class="csl-right-inline">Gardner DM, Teehan MD. <a href="https://doi-org.proxy.kib.ki.se/10.1017/CBO9780511919237"><span class="nocase">Antipsychotics and their Side Effects</span></a>. Cambridge University Press: 2010 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">153. </div><div class="csl-right-inline">Stahl SM, Shayegan DK. <span class="nocase">The Psychopharmacology of Ziprasidone: Receptor-Binding Properties and Real-World Psychiatric practice</span>. <span>J Clin Psychiatry</span> 2003; 64 Suppl 19: 6–12</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">154. </div><div class="csl-right-inline">Habibi M, Hart F, Bainbridge J. <a href="https://doi.org/10.1007/s11910-016-0670-5"><span class="nocase">The Impact of Psychoactive Drugs on Seizures and Antiepileptic Drugs</span></a>. <span>Curr Neurol Neurosci Rep</span> 2016; 16: 71</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">155. </div><div class="csl-right-inline">Woosley R, Heise C, Gallo T, Woosley D, Romero K. QTdrugs list. 2022</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">156. </div><div class="csl-right-inline">Pearce JM. <a href="https://doi.org/10.1159/000109581"><span class="nocase">Leopold Auenbrugger: Camphor-Induced Epilepsy - Remedy for Manic psychosis</span></a>. <span>Eur Neurol</span> 2008; 59: 105–7</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">157. </div><div class="csl-right-inline">Gazdag G, Bitter I, Ungvari GS, Baran B, Fink M. <a href="https://doi.org/10.1097/YCT.0b013e31819359fc"><span class="nocase">L<span class="nocase">á</span>szl<span class="nocase">ó</span> Meduna’s Pilot Studies With Camphor Inductions of Seizures: the First 11 patients</span></a>. <span>J ECT</span> 2009; 25: 3–11</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">158. </div><div class="csl-right-inline">Cerletti U, Bini L. <a href="https://doi.org/10.1080/09540261.2018.1436662"><span>Electroshock</span></a>. <span>Int Rev Psbychiatry</span> 2018; 30: 153–4</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">159. </div><div class="csl-right-inline">Carlbring SB, editor. <span>ECT</span>, kliniska riktlinjer. Svenska psykiatriska f<span>ö</span>reningen: 2014 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">160. </div><div class="csl-right-inline">Kellner CH, Knapp RG, Petrides G, et al. <a href="https://doi.org/10.1001/archpsyc.63.12.1337"><span class="nocase">Continuation Electroconvulsive Therapy Vs Pharmacotherapy for Relapse Prevention in Major Depression: a Multisite Study From the Consortium for Research in Electroconvulsive Therapy (CORE)</span></a>. <span>Arch Gen Psychiatry</span> 2006; 63: 1337–44</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">161. </div><div class="csl-right-inline">Petrides G, Fink M, Husain MM, et al. <a href="https://doi.org/10.1097/00124509-200112000-00003"><span class="nocase">ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: a Report From CORE</span></a>. <span>J ECT</span> 2001; 17: 244–53</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">162. </div><div class="csl-right-inline">UK ETC Group. <a href="https://doi.org/10.1016/S0140-6736(03)12705-5"><span class="nocase">Efficacy and Safety of Electroconvulsive Therapy in Depressive Disorders: a Systematic Review and meta-Analysis</span></a>. <span>Lancet</span> 2003; 361: 799–808</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">163. </div><div class="csl-right-inline">Diermen L van, Ameele S van den, Kamperman AM, et al. <a href="https://doi.org/10.1192/bjp.2017.28"><span class="nocase">Prediction of Electroconvulsive Therapy Response and Remission in Major Depression: meta-Analysis</span></a>. <span>Br J Psychiatry</span> 2018; 212: 71–80</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">164. </div><div class="csl-right-inline">Nordenskjöld A, Knorring L von, Engström I. <a href="https://doi.org/10.1186/1471-244X-12-115"><span class="nocase">Predictors of the Short-Term Responder Rate of Electroconvulsive Therapy in Depressive Disorders–a Population Based study</span></a>. <span>BMC Psychiatry</span> 2012; 12: 115</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">165. </div><div class="csl-right-inline">Frankel FH, Bidder TG, Fink M, et al. Report on the task force on electroconvulsive therapy. <span>American Psychiatric Association</span>, <span>Washington, D.C</span>: 1978 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">166. </div><div class="csl-right-inline">American Psychiatric Association Committee on Electroconvulsive Therapy, editor. <span class="nocase">The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging: A task force report of the American Psychiatric Association</span>. 2nd ed. <span>American Psychiatric Association. </span>: 2001 </div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">167. </div><div class="csl-right-inline">Socialdepartementet. <a href="https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/lag-19911128-om-psykiatrisk-tvangsvard_sfs-1991-1128"><span class="nocase">Lag (1991:1128) om psykiatrisk tv<span class="nocase">å</span>ngsv<span class="nocase">å</span>rd</span></a>. 1991</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">168. </div><div class="csl-right-inline">Socialstyrelsen. <a href="https://www.socialstyrelsen.se/regler-och-riktlinjer/foreskrifter-och-allmanna-rad/konsoliderade-foreskrifter/200818-om-psykiatrisk-tvangsvard-och-rattspsykiatriskvard/"><span class="nocase">SOSFS 2008:18 Socialstyrelsens f<span class="nocase">ö</span>reskrifter och allm<span class="nocase">ä</span>nna r<span class="nocase">å</span>d om psykiatrisk tv<span class="nocase">å</span>ngsv<span class="nocase">å</span>rd och r<span class="nocase">ä</span>ttspsykiatrisk v<span class="nocase">å</span>rd</span></a>. 2008</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">169. </div><div class="csl-right-inline">Regeringen. <a href="https://www.riksdagen.se/sv/dokument-lagar/dokument/proposition/om-psykiatrisk-tvangsvard-mm_GE0358"><span class="nocase">Regeringens proposition 1990/91:58 om psykiatrisk tv<span class="nocase">å</span>ngsv<span class="nocase">å</span>rd, mm</span></a>. 1990</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">170. </div><div class="csl-right-inline">Schulte-van Maaren YWM, Carlier IVE, Zitman FG, et al. <a href="https://doi.org/10.1016/j.jad.2013.02.009">Reference values for major depression questionnaires: <span>The</span> <span>Leiden</span> <span>Routine</span> <span>Outcome</span> <span>Monitoring</span> <span>Study</span></a>. Journal of Affective Disorders 2013; 149: 342–9</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">171. </div><div class="csl-right-inline">Faggion Jr CM, Menne MC, Pandis N. <a href="https://doi.org/10.1111/eos.12827">Prediction intervals should be included in meta-analyses published in dentistry</a>. European Journal of Oral Sciences 2021; 129: e12827</div>
</div>
<div class="csl-entry">
<div class="csl-left-margin">172. </div><div class="csl-right-inline">Wit S de, Dickinson A. <a href="https://doi.org/10.1007/s00426-009-0230-6">Associative theories of goal-directed behaviour: A case for animal-human translational models</a>. Psychol Res 2009; 73: 463–76</div>
</div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="ordlista.html" class="navigation navigation-prev navigation-unique" aria-label="Previous page"><i class="fa fa-angle-left"></i></a>

    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": null,
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": null,
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "subsection",
"scroll_highlight": true
},
"toc_depth": 3,
"toolbar": {
"position": "fixed"
},
"info": true
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.9/latest.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
